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The influence of water soluble and insoluble stabilizing excipients on the physical 
stability of coated dosage forms was investigated in this study.  The effect of the 
excipients on the thermal and physico-mechanical properties, and water vapor 
permeability of free films was studied, as was the influence of these excipients on the 
physical stability and release kinetics of coated pellets. 
The effect of water-soluble proteins, bovine serum albumin (BSA) and Type B 
gelatin, on the physical aging of Eudragit® RS/RL 30 D films was investigated.  It was 
found that ionic interactions occurred above the isoelectric point of BSA and caused 
unstable films which showed accelerated decreases in drug release rate.  The adjustment 
of the pH of the dispersion below the isoelectric point of BSA resulted in electrostatic 
repulsive charges that stabilized the drug release rate from coated dosage forms at both 
ambient and accelerated conditions.  The addition of gelatin to the coating dispersion 
increased the drug release rate due to the formation of gel-domains through which the 
drug was able to easily diffuse.  The influence of silicon dioxide on the stability of 
 viii
Eudragit® RS/RL 30 D films was investigated.  Colloidal grades showed enhanced 
incorporation in the acrylic matrix; however, unstable films were formed.  The addition 
of silicon dioxide with a larger particle size increased the permeability of the film and 
stabilization in drug release rate was attributed to constant water vapor permeability 
values of free films.  The influence of ethylcellulose on the physical aging of Eudragit® 
NE 30 D coated pellets was studied.  The two polymers were found to be substantially 
immiscible and the drug release rate of coated pellets was constant at both ambient and 
accelerated conditions which correlated to stabilizations in both the physico-mechanical 
properties and water vapor permeability of free films.  Blending both Eudragit® NE 30 D 
and RS 30 D resulted in the formation of coherent films without the need of plasticizer.  
The two polymers were found to be miscible and both films and coated dosage forms 
were stable when stored below the glass transition temperature of the polymer blend.  
When films were stored above this temperature, instabilities occurred as a result of the 
further coalescence and densification of the polymer blend.   
 ix
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Chapter 1: Introduction – Physical Aging of Polymers and Its Effect on 
the Stability of Solid Oral Dosage Forms1  
1.1 FILM FORMATION FROM AQUEOUS LATEX AND PSEUDOLATEX DISPERSIONS 
Film-coating is an effective method to modify drug release from tablets and 
pellets.  Aqueous-based coating technology is becoming more popular due to the 
stringent requirements by environmental and regulatory bodies which restrict the use of 
organic solvents in production. The formation of thin, transparent films from aqueous-
based latex or pseudolatex dispersions occurs with the simultaneous evaporation of water 
[1, 2] in three stages.  During the coating process (stage 1), water evaporates from the 
film-coated substrate at a constant rate.  The latex particles begin to pack together and 
fuse to form a continuous film.  As the colloidal particles begin to fuse and coalesce, 
stage 2, the rate of water evaporation decreases.  By stage 3, film formation is considered 
complete; however, it is during stage 3 that changes occur in the drug release rate due to 
physical aging of the polymeric film coating.  
1.2 A HISTORY OF PHYSICAL AGING 
Physical aging, or enthalpy relaxation, has been known to polymer scientists for 
many years.  All amorphous polymers show physical aging, where the material becomes 
more rigid, brittle, and dense with time [3].  In the text titled “Physical Aging in 
Amorphous Polymers and Other Materials” [4], Struik discussed the early work of Simon 
[5] who had shown that amorphous materials were not in thermodynamic equilibrium at 
temperatures below their glass transition temperature.  The dynamic state is a result of the 
materials possessing a volume, enthalpy, and entropy that are greater than in the 
equilibrium state.  The free volume concept states that transport mobility of particles in a 
                                                 
1 Published in part by: Kucera, S.A., et al.  (In Press, 2008) ‘Chapter 15: Physical Aging of Polymers and 
Its Effect on the Stability of Solid Oral Dosage Forms’ in McGinity, J.W. & Felton, L.A. (eds.) Aqueous 
polymeric coatings for pharmaceutical dosage forms, 3rd edn.  New York: Informa Healthcare, USA.  pp. 
447-476. 
 2
closely packed system primarily depends on the degree of packing, or the free volume.  
When the polymer is cooled to some temperature below it glass transition temperature 
(Tg), the mobility will be small, but not zero.  At this stage, the free volume is greater 
than it would be at equilibrium and the volume will decrease slowly [4, 6].  This 
contraction is accompanied by a decrease in the polymer chain mobility, which leads to a 
densification of the polymer, influencing both porosity and tortuosity [6, 7]. 
1.3 THE EFFECT OF PHYISCAL AGING ON DIFFUSIONAL DRUG RELEASE 
Diffusion of a drug molecule through a thin film is governed by Fick’s First Law 
of Diffusion: 
 
   h
tCCSDQ ×−××= )( 21
                                                                          (Eq. 1.1) 
where Q (the amount of drug diffused over a period of time, t) is a function of h, 
the film thickness; S, the surface area available for diffusion; C1, the concentration of 
drug in the donor compartment; C2, the concentration of drug in the acceptor 
compartment, and D, the diffusion coefficient of the drug. The physical aging of a 
polymeric film results in a change in the diffusion coefficient [7, 8], which can be shown 




                                                                                                 (Eq. 1.2) 
where Dw is the diffusion coefficient of the drug in water. D is the diffusion 
coefficient of the drug and is a function of both the film’s porosity, e, and tortuosity, τ. 
As a film ages, it becomes more dense [3], resulting in a decrease in film porosity and an 
increase in tortuosity, thus causing a decrease in the dissolution rate of drug from film-
coated dosage forms over time [7]. 
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1.4 METHODS OF QUANTIFYING PHYSICAL AGING 
The physical changes in pharmaceutical polymers resulting from aging can be 
evaluated and quantified by a number of analytical methods, including measurement of 
the Tg, typically done by differential scanning calorimetry (DSC), analysis of mechanical 
properties or film permeability, dissolution of drug from a coated dosage form, and by 
free volume measurements.  The presence of drug crystals on the surface of the coating, 
which can also indicate polymer aging, can be studied using powder x-ray diffraction 
(PXRD) and scanning electron microscopy (SEM). 
1.4.1 Mechanical Analysis 
When a polymer is cooled below its glass transition temperature, the amorphous 
material has a higher specific volume, enthalpy, and entropy than the equilibrium state 
would possess at the same temperature [9].  The structural changes in the glassy state due 
to relaxation of the polymer can manifest changes in the physical properties that are of 
critical importance to pharmaceutical scientists.   These changes include decreases in 
elongation [7, 9, 10] and creep compliance [11] as well as increases in elastic modulus [9, 
10] and tensile stress [7, 10].  These parameters are all quantifiable by examining the 
physical-mechanical properties of polymeric films as a function of time and storage 
conditions. 
1.4.1.1 Unilateral Stress-Strain 
A simple method to examine the physical-mechanical properties of polymeric 
films is by unilateral stress-strain experiments [6, 7, 10-18].  Changes in the internal 
structures of polymers strongly affect their physical and mechanical properties [19] and 
the results from stress-strain experiments allow the researcher to gather information on 
the tensile properties, modulus, and elongation of thin films [7].  The industry standard 
for these measurements is published by the American Society for Testing Materials 
(ASTM) D 882-02: Standard Test Method for Tensile Properties of Thin Plastic Sheeting 
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[20].   The specimen to be tested should have a thickness of less than 1.0 mm, a width 
between 5.0 and 25.4 mm, and should be at least 50 mm longer than the grip separation.  
If possible, the specimens used for the test should have an overall thickness that is 
uniform within 10%. 
To begin testing, the film specimen is placed in the grips of an instrument such as 
an Instron testing device.  One grip of the device is fixed, while the other is allowed to 
move at a constant rate.  As the movable grip is extended, the film is subjected to strain, 
which is recorded by the instrument with either a tracer/plotter attachment or, as seen in 
newer equipment, a computer having specialized software packages.  These software 
packages, such as Bluehill distributed by Instron, allow for the automatic calculation of 
such parameters as tensile strength at break or maximum load, percent elongation, and 
the elastic or Young’s modulus of a film specimen. 
1.4.1.2 Creep Compliance 
Creep testing is another common method that allows scientists to measure the 
changes in physical-mechanical properties of a polymer as it ages [6, 11, 14, 17, 21-27].  
Creep is the progressive deformation of a material at a constant load.  Creep tests 
measure the dimensional changes that occur over time under a constant static load that is 
applied to the specimen at a set temperature [28].   
The creep of a specimen occurs in 3 stages.  Following an initial rapid elongation 
upon application of the load, the creep rate decreases rapidly with time during Stage 1.  
Stage 2 is denoted by the attainment of a steady state with respect to creep rate.  Stage 3 
is characterized by a rapid increase in creep rate followed by fracture of the specimen.  
Graphically, when plotted as a log-log plot, the creep compliance of a material is linear in 
relation to time [28].  During physical aging, creep compliance decreases as indicated by 
an increase in the slope of creep modulus versus time on a log-log plot. 
The industry standard for creep testing is ASTM D 2990-01: Standard Test 
Methods for Tensile, Compressive, and Flexural and Creep-Rupture of Plastics [28].  
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Specimens for tensile creep measurements should conform to the same standards as those 
used in unilateral stress-strain experiments.  For this experiment, the film sample is first 
placed between two clamps and then annealed by raising the temperature about 10-20°C 
higher than the polymer’s Tg and cooled or quenched to some pre-defined temperature 
below the Tg of the polymer for a period of time, usually a few minutes. 
1.4.2 Membrane Permeability 
Measuring the vapor permeability of a film as a function of time and aging 
conditions has been previously used to qualitatively analyze physical aging in thin 
polymeric films [7, 11, 13, 15, 24, 29-37].  As the film undergoes further gradual 
coalescence, its permeability to a gas will decrease due to increases in film density and 
tortuosity.  As physical aging progresses, a decrease in water vapor transmission rate is 
typically observed. 
1.4.2.1 Water Vapor Permeability 
The water vapor transmission rate is the steady flow of water vapor per unit time 
through a unit area under specific conditions of temperature and humidity [38].  A useful 
guideline is published by the American Society for Testing Materials (ASTM) E 96/E 96 
M-05.  The guideline describes two methods for determining the moisture vapor 
permeability of a thin film.  One method, known as the desiccant method, involves 
placing a thin polymer film over the opening of a cup containing anhydrous calcium 
chloride as a desiccant.  The film is secured and the apparatus is placed in a constant-
temperature, constant-humidity environment.  The cup is weighed periodically and a 
graph of weight vs. time is plotted.  The second method is called the water method and 
the cup contains a saturated salt solution of known relative humidity rather than a 
desiccant. With this method, the permeability of the film is evaluated by quantifying the 
transfer of water vapor from the cup through the specimen to a controlled atmosphere 
over time.  
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                                                                                                    (Eq. 1.3) 
 
where WVT is the water vapor transmission in g/h·m2, (G/t) is the slope of the line 
from the weight gain vs. time plot, and A is the surface area of the film.  These data can 
be used to calculate the permeability of a thin film.  Permeability is simply the arithmetic 
product of permeance and thickness, where permeance is the rate of water vapor 
transmission through the film as a function of vapor pressure differences between the two 
surfaces. Permeance is a performance measure of the film, whereas permeability is a 










                                                               (Eq. 1.4) 
where S is the saturation vapor pressure at test temperature, R1 is the relative 
humidity at the source (in the chamber for the desiccant method and in the cup for the 
water method), and R2 is the relative humidity at the vapor sink.  The permeability of the 
film is calculated by multiplying the thickness of the film by its permeance. 
1.4.3 Free Volume Measurements 
1.4.3.1 Ellipsometry 
Ellipsometry is an optical technique for measuring the dielectric properties (i.e., 
refractive index) of thin films [34-36, 39-41].  Huang and Paul first reported on the use of 
ellipsometry in monitoring the physical aging of thin glassy films by changes in 
refractive index [39].  This method has the advantage that no damage is done to the film 
specimen, allowing the same sample to be examined throughout an aging study.   
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The Lorentz-Lorenz parameter (L) is derived from the Lorentz-Lorenz equation 

















                                                           (Eq. 1.5)  
 
and shows that the refractive index (n) is directly related to ρ, the density of the 
polymer, where Nav is Avogadro’s number, α is the average polarizability of the polymer 
repeat unit, M0 is the molecular weight of the polymer repeat unit, and ε0 is the 
permittivity of free space constant.   
The Lorentz-Lorenz parameter (equation 1.5) can also be related to the density of 
a polymer by equation 1.6 [41]: 
 
C ρL =                                                                                     (Eq. 1.6) 
where ρ is the density of the material and C is a material constant from the bulk 
values of refractive index and density at 25°C [41].   The fractional free volume, f, at any 
time is then determined by equation 1.7 [41]: 
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                                               (Eq. 1.7) 
where V=1/ρ is the specific volume at that aging time, V0 is the occupied volume 
of the polymer computed from the van der Waals volume of the polymer, Vw, by the 
Bondi method, where V0=1.3Vw  [41]. 
1.4.3.2 Positron Annihilation Spectoscopy (PALS) 
Another method used to quantify the changes in free volume due to the physical 
aging of polymeric films is by the use of positron annihilation spectroscopy (PALS) [17, 
42-45].  This method is able to measure the free volume as well as the free volume 
distribution in a polymeric film [17, 44, 46].  The positron is a particle that has the same 
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properties of an electron, however, with an opposite charge.  When a positron and an 
electron meet, it is likely that a positronium atom will form [46].  There are two possibile 
positronium “states” that can exist:  the para-positronium (p-Ps) and the ortho-
positronium (o-Ps).  While the p-Ps state has a very short life of about 125 ps [46] in a 
vacuum, the o-Ps has a relatively long lifetime of about 142 ns [46] under the same 
conditions and a lifetime of about 1-10 ns in a polymer [44].  When the o-Ps atom 
annihilates, three gamma rays are emitted and detected to determine the lifetime of the 
particle. 
In a PALS experiment, a radioactive sample of 22NaCl [22, 44, 46] is used to 
inject lone positrons into the polymer sample.  The lifetime of the positron in the sample 
(λ) is therefore due to the electron density at the location of the positron according to 
equation 1.8 [44]: 
 
∫ −+= dVC ρρλ ,                                                                                       (Eq. 1.8) 
where C is a constant and ρ+ and ρ- are the positron and electron densities, 
respectively.  The lifetime of the o-Ps particle (in nanoseconds), τ, is described by 































,                                                    (Eq. 1.9) 
where R is the radius of the spherical free volume holes and ΔR represents the 
thickness of the electron layer which is a constant of 1.656Å [22, 46].  Thus, there is a 
direct correlation between the lifetime of the o-Ps and the size of the free volume voids in 
the polymer matrix [22]. 
1.4.4 Thermal and Microscopic Analysis 
Differential scanning calorimetry (DSC) is a common analytical method used to 
determine various polymer properties, including melting temperature, degree of 
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crystallinity, Tg, and enthalpy of transition. The technique is widely used to investigate 
excipient-polymer interactions and evaluate the effectiveness of plasticizing agents in 
polymeric films. A film sample and a reference are heated at a programmed rate and 
more energy is absorbed (or emitted) in the sample during a phase change. The energy or 
heat flow is plotted against temperature or time and software programs are used to 
determine the desired property. During physical aging, there is a decrease in enthalpy or 
enthalpy of relaxation and can be measured by DSC.  This parameter is commonly used 
to study physical aging and can be determined by integrating the endothermal peak 
present in the Tg region during the initial scan [47].  As the polymer ages, both the peak 
size and the temperature corresponding to its maximum will increase [17, 47].  
Polymer films may contain various additives such as endogenous emulsifiers, 
active pharmaceutical ingredients, or excipients that either improve processability or 
modify drug release from the coated dosage forms.  In some cases, the polymer may be 
stored at a temperature above the Tg.  At this point, the specific volume of the polymer is 
large as is the molecular mobility of the polymer and it is possible for the additive 
components to crystallize during storage.  Techniques such as DSC, PXRD, and SEM can 
be used to scan the polymeric films to determine if crystal growth is present. 
1.5 VARIABLES THAT INFLUENCE PHYSICAL AGING 
1.5.1 Plasticizers 
Plasticizers reduce the intermolecular attractions between polymer chains to 
increase the flexibility of the resulting film and enhance the formation of thin films from 
aqueous lattices. The selection of a plasticizer is of the utmost importance when 
formulating a coating dispersion.  Plasticizers must remain in the film, exhibiting little or 
no tendency for migration or volatilization. Moreover, plasticizers must be compatible 
with the polymer. Using a plasticizer that is incompatible with an aqueous latex can result 
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in poor film formation and instabilities with respect to drug release over time during 
storage. 
Once incorporated, the plasticizing agent should remain in the polymeric matrix 
in order to produce a stable film.  The permeability and mechanical strength of Eudragit® 
RS and RL films were found to be a function of plasticizer remaining in the film [30].  
Both films exhibited a decrease in plasticizer content after 6 months of storage at 
25°C/0% RH and a concomitant decrease in the elongation at break.  In contrast, the 
permeability of RS films decreased during this time period, while the RL films 
demonstrated an increase in permeability.  These results were attributed to the 
volatilization of the plasticizer. The loss of plasticizer was less critical for the more 
hydrophilic RL polymer, with the void space being quickly filled by the permeant 
solution, thus resulting in an increase in permeation.  
The addition of a proper amount of plasticizer to the coating dispersion is also of 
considerable importance.  Incorporation of an inadequate amount of plasticizer in the 
formulation can result in polymer films that are brittle or that require longer curing times 
to exhibit stable films.  The degree of coalescence of latex particles at the end of the 
coating process is a function of the concentration of plasticizer in the formulation, with 
higher concentrations of plasticizer producing enhanced or more complete film 
formation. In one study, theophylline release from pellets coated with Eudragit® RS 30 D 
containing 5% Pharmacoat 606 and 10 or 20% TEC as a plasticizer was investigated [48].  
The time to achieve a stable drug release rate at storage conditions of 40°C and 50% 
relative humidity ranged between 6 months and 10 days for formulations containing 10% 
and 20% plasticizer, respectively. 
1.5.2 Curing and Storage Conditions 
After completion of the coating process, coated dosage forms are often stored at 
elevated temperatures to promote further gradual coalescence of the film, a process 
known as curing. Curing of film-coated dosage forms is an important component in the 
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film-formation mechanism of thin films from aqueous lattices.  The film formation 
process from these aqueous dispersions relies on capillary forces to draw together and 
deform the latex particles and is influenced by the amount of water in the polymeric film.  
As the amount of water in the polymer film increases, the Tg of the film is lowered, 
resulting in an increased mobility of the polymer chains which in turn enhances the 
further coalescence of the latex particles.  As the humidity of the environment is 
decreased, the amount of water in the polymeric film is reduced and consequently the 
capillary forces that facilitate film formation are not present. 
Although the presence of water can help to enhance the coalescence of polymeric 
films during curing, high levels of humidity during storage can destabilize the films, 
leading to changes in the drug release rate over time.  Water will function as a plasticizer 
in film-coated dosage forms and enhance coalescence of polymeric films during storage, 
which will generally result in a decrease in the drug release rate.  
Both curing temperature and curing time significantly affect the drug release rate, 
but curing temperature is of greater consequence [49-51].  Lin and coworkers [50] 
showed a decrease in the dissolution rate of diphenhydramine from pellets coated with a 
10% weight gain of Eudragit® NE 30 D at curing temperatures of 30°C, 45°C, and 60°C.  
The decrease in release rate of the product stored at 30°C was small (when compared to 
other temperatures) and not significantly affected by length of curing time.  However, as 
temperature and storage time were increased, the changes observed in the dissolution rate 
were amplified.  It is suggested that in order for the polymer to achieve a stable energetic 
state, energy is required to overcome existing barriers that cause the stable state to be 
kinetically disfavored.  At higher temperatures, more polymer molecules can overcome 
this energy barrier and reach the stable state, which is reflected by a slower drug release 
rate.  On the other hand, at lower curing temperatures, fewer molecules can achieve the 
stable state, meaning that changes in drug release would be expected to occur slowly over 
time until this stable state is reached.  
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Changes in drug release during curing have also been reported for high glass 
transition temperature polymers, such as ethylcellulose, in dosage forms coated with 
Aquacoat® ECD.  Physical instabilities in the coating can cause cracking and chipping of 
the film coating; however, researchers attributed these problems to an increase in the 
water content of the films rather than a decrease [31].  Incomplete film formation and 
further gradual coalescence during storage of dosage forms coated with Aquacoat® will 
cause instability in the drug release rate. Contrary to the stability problems seen in acrylic 
polymers, uncured Aquacoat® ECD films actually exhibited an increase in drug 
dissolution rate, rather than a decrease.  Faster drug release may be caused by brittle films 
or the formation of microruptures in the film coat during storage [52].  For films cast 
from an organic solution, there is a significant shift in creep compliance as aging 
progresses, indicating a decrease in free volume of the film and increased compaction of 
the polymer structure.  These changes were also responsible for a reduction in the water 
vapor permeability coefficient as a function of aging time [11].  For aqueous-based films, 
a decrease in free volume was noted as a result of further gradual coalescence of the 
pseudolatex particles [13]. 
1.5.3 Endogenous Excipients 
The presence of endogenous excipients in aqueous coating systems is often 
necessary to stabilize the dispersion during storage.  In other cases, excipients are used in 
the emulsion polymerization process of aqueous lattices, as is the case of nonoxynol 100 
in Eudragit® NE 30 D dispersions.  However, the presence of this emulsifier can lead to 
serious stability issues, such as an increase in drug dissolution rate during storage [53].  
Due to the relatively high melting point of the surfactant (~60°C), it is possible for the 
material to crystallize within the film during storage at room temperature.  Studies have 
shown that crystallization of the surfactant affects the dissolution rate of drug from 
coated dosage forms [54].  Further gradual coalescence and drug release from coated 
pellets were influenced by increasing amounts of nonoxynol 100 in the coating 
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dispersions [54].  When a commercially available Eudragit® NE 30 D dispersion (1.5% 
nonoxynol 100) was used to coat pellets, the drug release rate diminished by 10% over 
two months storage at room temperature, while a decrease of only 5% was observed 
when the nonoxynol 100 concentration was 5%.  However, when the surfactant 
concentration was increased to 10%, there was first a decrease in the dissolution rate of 
the drug as a result of the initial swelling of the polymer, after which the dissolution rate 
of the drug increased.  This phenomenon was the result of further coalescence of the 
polymer, which decreased the drug release rate, coupled with the dissolution of surfactant 
crystals, which caused large pores in the film and enhanced the release of the drug [54]. 
The crystallization of nonoxynol 100 in Eudragit® NE 30 D free films has also 
been followed via calorimetric studies [55].  These studies showed the melting point of 
nonoxynol 100 as a single endothermic peak at around 55°C for freshly cast films of 
Eudragit® NE 30 D.  The films were stored at ambient conditions (25°C/<35% RH), 
25°C/60% RH, and 40°C/75% RH and analyzed via DSC at periods of 1, 2, and 4 weeks.  
As time progressed, all films showed an increase in the magnitude of the melting point 
endotherm of nonoxynol 100, indicating crystal growth of the surfactant in the film, 
which agrees with earlier data published by Lin and Augsburger [54].  The study also 
concluded that lower temperatures caused a higher degree of crystallization of the 
emulsifying agent. 
Positron annihilation lifetime spectroscopy was used to measure the distribution 
of free volume holes in cast films of Eudragit® NE 30 D with and without nonoxynol 100 
[44].  When the emulsifying agent was not present in the film, the size distribution of free 
volume holes remained unchanged when stored for 30 days at 25°C/75% RH.  When 
nonoxynol 100 was present in the film however, the size distribution of the free volume 
holes narrowed and was more uniform following initial sample preparation.  During one 
month’s storage at conditions of high humidity, water initiated an absorption-dissolution 
transition in these films and the size distribution of the free volume holes in the polymer 
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increased.  This report confirms earlier studies [50, 54, 55] that indicated nonoxynol 100 
affects the long-term stability of Eudragit® NE 30 D films. 
1.6 METHODS USED TO STABILIZE/PREVENT AGING 
1.6.1 Increased Plasticizer Concentration 
Plasticizers lower both the glass transition temperature and the minimum film 
formation temperature of the polymer.  Furthermore, the degree of coalescence of latex 
particles at the completion of the coating process increases as the amount of plasticizer in 
the formulation increases due to the plasticizer's ability to weaken polymeric 
intermolecular attractions thus allowing the polymer molecules to move more readily, 
increasing the flexibility of the polymer.  For example, theophylline pellets coated with a 
formulation containing Eudragit® RS 30 D, 5% Pharmacoat 606, 50% talc, and 30% TEC 
showed virtually no change in dissolution rate upon storage [48].   
While liquid plasticizers can be lost through evaporation during storage, solid-
state plasticizers have the distinct advantage of remaining in the film through the life of 
the dosage form.   Studies have been conducted in which non-pareil beads were coated 
with Eudragit® RS 30 D containing 40% ibuprofen as the active ingredient and solid-state 
plasticizer [56].  The coated beads were cured at 40°C for a period of 24 hours and then 
stored at 23°C and 0% relative humidity.  No significant difference was found between 
the initial drug release rate and the drug release profiles of the stored samples. The 
authors reported that the presence of ibuprofen in the coating also served as an anti-
adherent, preventing the agglomeration of pellets during the coating process and 
subsequent storage. 
1.6.2 Curing and Storage 
The conditions at which dosage forms are cured, as well as stored, can have a 
significant effect on the stability of the polymeric film.  When dosage forms are cured at 
high temperatures, the time required to reach a fully coalesced film decreases in 
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comparison to curing at lower temperatures [52].  At temperatures above the Tg of the 
film, the mobility of the polymer chains increases and latex coalescence is accelerated so 
that films are nearly completely coalesced when removed from the coating apparatus. 
Humidity in the environment during storage can significantly influence drug 
release from coated dosage forms.  Water vapor in the atmosphere which is adsorbed by 
the polymeric films can act as a plasticizer, increasing the molecular mobility of the 
polymer and aiding in the densification and further coalescence of the polymer.  In the 
case of acrylic films cast from organic solutions [11], the time required for a fully 
coalesced film to form was shown to be longer than the same film cast from an aqueous 
system.  Curing of these films at low humidity conditions under vacuum was not 
effective for removing the solvent from the films; however, higher humidity conditions 
were found to facilitate solvent removal. 
1.6.3 Addition of High Glass Transition Temperature Polymers 
The addition of a miscible, high glass transition polymer is another method which 
has been shown to stabilize drug release from sustained release coatings.  Stabilization 
occurs by decreasing molecular mobility of the polymer film by increasing the Tg of the 
polymer blend.  High glass transition temperature polymers also serve as a framework to 
resist the densification and further coalescence of a continuous phase with a much lower 
glass transition temperature.  As an example, Eudragit® L 100-55 was found to be 
miscible with Eudragit® RS 30 D [57], and although the enteric polymer increased the 
drug release rate from coated theophylline pellets as the pH of the dissolution media 
increased, the product exhibited no physical aging when stored at 40°C, i.e. a static drug 
release profile over time.  Another study [58] showed that  the addition of 16.7% 
Eudragit® L 30 D-55 to Eudragit® NE 30 D decreased the tackiness of the films and, 
when cured at 60°C, the drug release rate of the coated pellets stabilized after 4 hours of 
storage. 
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1.6.4 High Solids Content 
Talc is traditionally used as an anti-tacking agent in the coating formulation and is 
usually present at concentrations of 50-100%.  Generally, the addition of higher amounts 
of talc is seldom used because the high solids content could alter drug release from the 
dosage form.  However, it has been shown that the inclusion of up to 200% talc can be 
used to successfully formulate coated pellets with a sustained drug release rate [59].  
When this amount of talc was added to a 95:5 blend of Eudragit® RS/RL 30 D plasticized 
with TEC, the acrylic polymer functioned as an effective binder for the talc, resulting in a 
continuous film coat. However, although film formation was incomplete, the coating still 
provided a sustained release of the drug.  The high talc content of the films also resulted 
in no agglomeration of the coated pellets during curing at 60°C or storage at 40°C/75% 
RH in open containers.  The authors stated that the addition of 10 or 20% TEC to the 
coating formulation resulted in dosage forms which were physically stable and no 
significant change in drug release rate was noticed during storage for 3 months. 
1.6.5 Addition of Immiscible, Hydrophilic Excipients 
Hydrophilic, water soluble polymers have found use in stabilizing sustained 
release polymers in coating applications. It has been shown that these excipients form 
boundaries which inhibit the further coalescence of the functional polymer.  For example, 
hydroxyethylcellulose (HEC) has been shown to stabilize the release rate of theophylline 
from pellets coated with Eudragit® RS 30 D [7].  Theophylline pellets coated with the 
acrylic polymer plasticized with 20% TEC exhibited a decrease in drug release rate 
during storage at 25°C/60% RH.  Cast films of the same formulation showed an increase 
in tensile strength and a decrease in water vapor transmission rate during storage over 1 
month.  The addition of 10% HEC to the coating formulation, however, stabilized the 
drug release profiles of the coated pellets stored at the same conditions.  Likewise, no 
changes were observed in the physical-mechanical properties or the water vapor 
transmission rate of the cast films containing HEC.  Atomic force microscopy (AFM) 
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was used to characterize the surface morphology of the cast films.  Films of Eudragit® RS 
30 D exhibited a smooth, regular surface where all latex particle boundaries had 
disappeared.  In contrast, a rough surface was observed for acrylic films containing 10% 
HEC. The hydrophilic polymer had surrounded the hydrophobic acrylic latex particles 
and prevented the further coalescence and densification of the film.  The HEC allowed 
the film structure to be retained during storage and stabilized the permeability and 
mechanical properties of the film. 
1.7 CONCLUSIONS 
Physical aging is a phenomenon that affects all polymers.  Simply utilizing 
alternative coating systems or polymers is not the solution to formulations that exhibit 
these stability issues.  The subject has been extensively discussed in the chemical 
engineering literature and is an important consideration during formulation development 
for pharmaceutical scientists.  Physical aging of polymers has been shown to cause 
changes in the physical-mechanical, permeability, and drug release properties of 
polymeric films due to a densification and decrease in free volume of the polymer as it 
relaxes to an equilibrated thermodynamic state. Since the coating of oral dosage forms 
with aqueous polymeric lattices is one of the simplest and most widely used methods for 
controlling drug release rates, the stability of these coated dosage forms is of the utmost 
importance.  Aging has been shown to be influenced by factors such as humidity and 
temperature during storage as well as excipients in the coating formulation. A number of 
techniques have been used to stabilize polymeric films and prevent aging. Care must be 
taken to both plan for and identify potential aging issues during the early stages of 
product development.  This includes determining the mechanism or mechanisms of 
destabilization, identifying the most appropriate stabilizer for the coating formulation, 
and ensuring that the coated dosage forms are cured to a point that film formation from 
the aqueous latex is complete.    
 18
1.8 REFERENCES 
1. Lin, F. and D.J. Meier. A Study of Latex Film Formation by Atomic Force 
Microscopy. 1. A Comparison of Wet and Dry Conditions. Langmuir, 1995. 11 
(7): p. 2726-2733. 
2. Lippold, B.C. and R.M. Pages. Film Formation, Reproducibility of Production 
and Curing with Respect to Release Stability of Functional Coatings from 
Aqueous Polymer Dispersions. Pharmazie, 2001. 56 (1): p. 5-17. 
3. Greiner, R. and F.R. Schwarzl. Volume relaxation and physical aging of 
amorphous polymers I. Theory of volume relaxation after single temperature 
jumps. Colloid & Polymer Science, 1989. 267 (1): p. 39-47. 
4. Struik, L.C.E. Chapter 1 - Scope of the Work, in Physical Aging in Amorphous 
Polymers and Other Materials, L.C.E. Struik, Editor. 1978, Elsevier Scientific 
Publishing Company: New York. p. 1. 
5. Simon, F. Z. anorg. allgem. Chem., 1931. 23 p. 219. 
6. Guo, J.-H. Aging processes in pharmaceutical polymers. Pharm. Sci. Technol. 
Today, 1999. 2 (12): p. 478-483. 
7. Zheng, W., D. Sauer, and J.W. McGinity. Influence of hydroxyethylcellulose on 
the drug release properties of theophylline pellets coated with Eudragit® RS 30 D. 
European Journal of Pharmaceutics and Biopharmaceutics, 2005. 59 (1): p. 147-
154. 
8. Iyer, U., W.-H. Hong, N. Das, and I. Ghebre-Sellaissie. Comparative evaluation 
of three organic solvent and dispersion-based ethylcellulose coating formulations. 
Pharm. Tech., 1990. 14 (9): p. 68-86. 
9. Priestley, R.D., C.J. Ellison, L.J. Broadbelt, and J.M. Torkelson. Structural 
Relaxation of Polymer Glasses at Surfaces, Interfaces, and In Between. Science, 
2005. 309 (5733): p. 456-459. 
10. Gutierrez-Rocca, J.C. and J.W. McGinity. Influence of Physical Aging on the 
Physical-Mechanical Properties of Acrylic Resin Films Cast from Aqueous 
Dispersions and Organic Solutions. Drug Dev. Ind. Pharm., 1993. 19 (3): p. 315-
332. 
11. Guo, J.-H., R.E. Robertson, and G.L. Amidon. Influence of Physical Aging on 
Mechanical Properties of Polymer Free Films: The Prediction of Long-Term 
Aging Effects on the Water Permeability and Dissolution Rate of Polymer Film-
Coated Tablets. Pharmaceutical Research, 1991. 8 (12): p. 1500-1504. 
12. Sinko, C.M., A.F. Yee, and G.L. Amidon. Prediction of Physical Aging in 
Controlled-Release Coatings: The Application of the Relaxation Coupling Model 
to Glassy Cellulose Acetate. Pharmaceutical Research, 1991. 8 (6): p. 698-705. 
 19
13. Guo, J.-H., R.E. Robertson, and G.L. Amidon. An Investigation into the 
Mechanical and Transport Properties of Aqueous Latex Films: A New Hypothesis 
for the Film-Forming Mechanism of Aqueous Dispersion System. Pharmaceutical 
Research, 1993. 10 (3): p. 405-410. 
14. Matsumoto, D.S. Time-temperature superposition and physical aging in 
amorphous polymers. Polymer Engineering & Science, 1988. 28 (20): p. 1313-
1317. 
15. Heng, P.W.S., L.W. Chan, and K.T. Ong. Influence of Storage Conditions  and 
Type of Plasticizers on Ethylcellulose and Acrylate Films Formed from Aqueous 
Dispersions. J Pharm Pharmaceut Sci, 2003. 6 (3): p. 334-344. 
16. Omari, D.M., A. Sallam, A. Abd-Elbary, and M. El-Samaligy. Lactic acid-
induced modifications in films of Eudragit® RL and RS aqueous dispersions. 
International Journal of Pharmaceutics, 2004. 274 (1-2): p. 85-96. 
17. Hutchinson, J.M. Physical aging of polymers. Progress in Polymer Science, 1995. 
20 (4): p. 703-760. 
18. Dai, C.-A. and M.-W. Liu. The effect of crystallinity and aging enthalpy on the 
mechanical properties of gelatin films. Materials Science and Engineering: A 
Mechanical Behaviour of Micro- and Nano-scale Systems, 2006. 423 (1-2): p. 
121-127. 
19. Drozdov, A.D. Physical aging in amorphous polymers far below the glass 
transition temperature. Computational Materials Science, 1999. 15 (4): p. 422-
434. 
20. ASTM. ASTM D 882-02 : Standard Test Method for Tensile Properties of Thin 
Plastic Sheeting. American Society for Testing Materials, 2002 
21. Barbero, E.J. and K.J. Ford. Equivalent Time Temperature Model for Physical 
Aging and Temperature Effects on Polymer Creep and Relaxation. Journal of 
Engineering Materials and Technology, 2004. 126 (4): p. 413-419. 
22. Bigg, D.M. A review of positron annihilation lifetime spectroscopy as applied to 
the physical aging of polymers. Polymer Engineering & Science, 1996. 36 (6): p. 
737-743. 
23. Drozdov, A.D. A Constitutive Model for Physical Ageing in Amorphous Glassy 
Polymers. Modelling Simul. Mater. Sci. Eng, 1999. 7 (6): p. 1045-1060. 
24. McCaig, M.S. and D.R. Paul. Effect of film thickness on the changes in gas 
permeability of a glassy polyarylate due to physical agingPart I. Experimental 
observations. Polymer, 2000. 41 (2): p. 629-637. 
 20
25. Montes, H., V. Viasnoff, S. Jurine, and F. Lequeux. Ageing in glassy polymers 
under various thermal histories. Journal of Statistical Mechanics: Theory and 
Experiment, 2006. (March): p. P03003. 
26. Pasricha, A., D.A. Dillard, and M.E. Tuttle. Effect of physical aging and variable 
stress history on the strain response of polymeric composites. Composite Science 
and Technology, 1997. 57 (9-10): p. 1271-1279. 
27. Sinko, C.M., A.F. Yee, and G.L. Amidon. The Effect of Physical Aging on the 
Dissolution Rate of Anionic Polyelectrolytes. Pharmaceutical Research, 1990. 7 
(6): p. 648-653. 
28. ASTM. ASTM D 2990-01: Standard Test Methods for Tensile, Compressive, and 
Flexuraly Creep and Creep-Rupture of Plastics. American Society for Testing 
Materials, 2001 
29. Ageeva, M.G. Moisture-resistant film coatings for orally administered medicinal 
forms. Pharmaceutical Chemistry Journal, 1970. 4 (6): p. 342-346. 
30. Anderson, W. and S.A.M. Abdel-Aziz. Ageing Effects in Cast Acrylate-
Methacrylate Film. J. Pharm. Pharmacol., 1976. 28 (Suppl: 22P):  
31. Chowhan, Z.T., A.A. Amaro, and L.-H. Chi. Comparative Evaluations of 
Aqueous Film Coated Tablet Formulations by High Humidity Aging. Drug Dev. 
Ind. Pharm., 1982. 8 (5): p. 713-737. 
32. Guo, J.-H. A Theoretical and Experimental Study of the Additive Effects of 
Physical Aging and Antiplasticization on the Water Permeability of Polymer Film 
Coatings. Journal of Pharmaceutical Sciences, 1994. 83 (3): p. 447-449. 
33. Heinämäki, J.T., V.-M. Lehtola, P. Nikupaavo, and J.K. Yliruusi. The mechanical 
and moisture permeability properties of aqueous-based hydroxypropyl 
methylcellulose coating systems plasticized with polyethylene glycol. 
International Journal of Pharmaceutics, 1994. 112 (2): p. 191-196. 
34. Huang, Y. and D.R. Paul. Experimental Methods for Tracking Physical Aging of 
Thin Glassy Polymer Films by Gas Permeation. J Membrane Sci, 2004. 244 (1-2): 
p. 167-178. 
35. Huang, Y. and D.R. Paul. Effect of Temperature on Physical Aging of Thin 
Glassy Polymer Films. Macromolecules, 2005. 38 (24): p. 10148-10154. 
36. Huang, Y. and D.R. Paul. Physical aging of thin glassy polymer films monitored 
by gas permeability. Polymer, 2004. 45 (25): p. 8377-8393. 
37. Tiemblo, P., J. Guzman, E. Riande, C. Mijangos, and H. Reinecke. Effect of 
physical aging on the gas transport properties of PVC and PVC modified with 
pyridine groups. Polymer, 2001. 42 (11): p. 4817-4824. 
 21
38. ASTM. ASTM E 96/E 96 M-05: Standard Test Methods for Waer Vapor 
Transmission of Materials. American Society for Testing Materials, 2005 
39. Huang, Y. and D.R. Paul. Physical Aging of Thin Glassy Polymer Films 
Monitored by Optical Properties. Macromolecules, 2006. 39 (4): p. 1554-1559. 
40. Kawana, S. and R.A.L. Jones. Effect of physical ageing in thin glassy polymer 
films. The European Physical Journal E - Soft Matter, 2003. 10 (3): p. 223-230. 
41. Huang, Y., X. Wang, and D.R. Paul. Physical aging of thin glassy polymer films: 
Free volume interpretation. Journal of Membrane Science, 2006. 277 (1-2): p. 
219-229. 
42. Chang, G.-W., A.M. Jamieson, Z. Yu, and J.D. McGervey. Physical aging in the 
mechanical properties of miscible polymer blends. Journal of Applied Polymer 
Science, 1997. 63 (4): p. 483-496. 
43. Kobayashi, Y., W. Zheng, E.F. Meyer, J.D. McGervey, A.M. Jamieson, and R. 
Simha. Free volume and physical aging of poly(vinyl acetate) studied by positron 
annihilation. Macromolecules, 1989. 22 (5): p. 2302-2306. 
44. Zelko, R., A. Orban, and K. Suvegh. Tracking of the physical ageing of 
amorphous pharmaceutical polymeric excipients by positron annihilation 
spectroscopy. Journal of Pharmaceutical and Biomedical Analysis, 2006. 40 (2): 
p. 249-254. 
45. Zelko, R., A. Orban, K. Suvegh, Z. Riedl, and I. Racz. Effect of plasticizer on the 
dynamic surface tension and the free volume of Eudragit® systems. International 
Journal of Pharmaceutics, 2002. 244 (1-2): p. 81-86. 
46. Cangialosi, D., H. Schut, A. van Veen, and S.J. Picken. Positron Annihilation 
Lifetime Spectroscopy for Measuring Free Volume During Physical Aging of 
Polycarbonate. Macromolecules, 2003. 36 (1): p. 142-147. 
47. Perera, D.Y. Effect of thermal and hygroscopic history on physical ageing of 
organic coatings. Progress in Organic Coatings, 2002. 44 p. 55-62. 
48. Amighi, K. and A.J. Moës. Influence of plasticizer concentration and storage 
conditions on the drug release rate from Eudragit® RS 30 D film-coated sustained-
release theophylline pellets. European Journal of Pharmaceutics and 
Biopharmaceutics, 1996. 42 (1): p. 29-35. 
49. Billa, N., K.-H. Yuen, and K.-K. Peh. Diclofenac release from Eudragit®-
containing matrices and effects of thermal treatment. Drug Dev. Ind. Pharm., 
1998. 24 (1): p. 45-50. 
 22
50. Lin, A.Y., N.A. Muhammad, D. Pope, and L.L. Augsburger. A Study on the 
Effects of Curing and Storage Conditions on Controlled Release 
Diphenhydramine HCl Pellets Coated with Eudragit® NE 30 D. Pharm. Dev. 
Tech., 2003. 8 (3): p. 277-287. 
51. Shao, Z.J., L. Moralesi, S. Diaz, and N.A. Muhammadi. Drug Release from 
Kollicoat® SR 30D-Coated Nonpareil Beads: Evaluation of Coating Level, 
Plasticizer Type, and Curing Condition. AAPS Pharm. Sci. Tech., 2002. 3 (2).  
52. Wesseling, M. and R. Bodmeier. Influence of Plasticization Time, Curing 
Conditions, Storage Time, and Core Properties on the Drug Release from 
Aquacoat-Coated Pellets. Pharm. Dev. Tech., 2001. 6 (3): p. 325-331. 
53. Amighi, K. and A.J. Moës. Influence of curing conditions on the drug release rate 
from Eudragit® NE 30 D film coated sustained-release theophylline pellets. S.T.P. 
Pharma Sci, 1997. 7 (2): p. 141-147. 
54. Lin, A.Y. and L.L. Augsburger. Study of Crystallization of Endogenous 
Surfactant in Eudragit® NE 30 D-Free Films and Its Influence on Drug-Release 
Properties of Controlled-Release Diphenhydramine HCl Pellets Coated with 
Eudragit® NE 30 D. AAPS PharmSci., 2001. 3 (2):  
55. Bajdik, J., K. Pintye-Hodi, G.J. Regdon, P. Fazekas, P. Szabo-Revesz, and I. Eros. 
The effect of storage on the behaviour of Eudragit® NE free film. Journal of 
Thermal Analysis and Calorimetry, 2003. 73 (2): p. 607-613. 
56. Wu, C. and J.W. McGinity. Influence of Ibuprofen as a Solid-State Plasticizer in 
Eudragit® RS 30 D on the Physicochemical Properties of Coated Beads. AAPS 
Pharm. Sci. Tech., 2001. 2 (4): p. 1-9. 
57. Wu, C. and J.W. McGinity. Influence of an Enteric Polymer on Drug Release 
Rates of Theophylline from Pellets Coated with Eudragit® RS 30 D. Pharm. Dev. 
Tech., 2003. 8 (1): p. 103-110. 
58. Zheng, W. and J.W. McGinity. Influence of Eudragit® NE 30 D Blended with 
Eudragit® L 30 D-55 on the Release of Phenylpropanolamine Hydrochloride from 
Coated Pellets. Drug Development and Industrial Pharmacy, 2003. 29 (3): p. 357-
366. 
59. Maejima, T. and J.W. McGinity. Influence of film additives on stabilizing drug 
release rates from pellets coated with acrylic polymers. Pharmaceutical 
Development and Technology, 2001. 6 (2): p. 211-221. 
 23
Chapter 2: Research Objectives 
2.1 OVERALL OBJECTIVES 
The objective of this study was to investigate the effects of water soluble and 
water insoluble excipients on the mechanisms of stabilization of acrylic films to prevent 
physical aging.  The effect of excipients on the thermal properties, the physical 
mechanical properties, and water vapor transmission rate of both sprayed and cast films 
was studied.  The mechanism of drug release due to stabilizing excipients was also 
investigated to examine the stability of dosage forms during storage. 
 
 2.2 SUPPORTING OBJECTIVES 
2.2.1 Investigate the Use of Proteins to Minimize the Physical Aging of Eudragit® 
RS/RL 30 D Sustained Release Films 
The addition of water-soluble, non-ionic excipients that are immiscible with the 
functional polymer has been shown to stabilize the drug release rate from coated pellets.  
In this study, the influence of immiscible proteins that exhibited ionic character, albumin 
and Type B gelatin,  were investigated as stabilizing excipients for theophylline pellets 
coated with Eudragit® RS and RL 30 D.  The physico-mechanical properties of sprayed 
films, thermal properties of cast films, protein influences on the zeta potential and 
particle size of the dispersions, and the release of proteins from cast films under 
simulated dissolution conditions were investigated.  The effect of temperature and 
humidity during storage on drug release from coated pellets was studied as well as the 
influence of pH of the Eudragit® polymeric dispersion on protein-polymer interactions. 
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2.2.2 Examine the Effect of Silicon Dioxide on Stabilizing Drug Release from 
Theophylline Pellets Coated with Eudragit® RS/RL 30 D 
The addition of a glidant is necessary during the fluidized bed coating of pellets to 
prevent the sticking of the multi-particulates during the process.  Previous work has 
revealed that when high levels of talc are present in the coating formulation a sustained 
release profile can be maintained and the dosage forms show good stability upon storage.  
Also, research in the past has shown that silicon dioxide can be successfully implemented 
as a glidant for the coating of multi-particulates.  The objective of this study was to 
investigate the influence of three grades of silicon dioxide (Cab-O-Sil® M-5P, Aerosil® 
200 VV, and Aeroperl® 300) on the physical aging and drug release of theophylline 
pellets coated with Eudragit® RS/RL 30 D.  Scanning electron microscopy was employed 
to examine the distribution of silicon dioxide in the film matrix.  The water vapor 
permeability and physico-mechanical properties of cast films were investigated as was 
the influence of storage conditions on the drug release from coated pellets.   
2.2.3 Study the Addition of Ethylcellulose as an Agent to Maintain the Physical 
Stability of Eudragit® NE 30 D Coated Theophylline Pellets 
Past research has shown that the stability of Eudragit® NE 30 D film-coated 
dosage forms can be enhanced by the addition of a miscible, high glass transition 
temperature, enteric polymer.  The aim of this study was to investigate how the addition 
of ethylcellulose (a non-enteric, high Tg polymer) affected the stability of Eudragit® NE 
30 D films and film-coated theophylline pellets.  The miscibility between the two 
polymers was probed with the use of modulated differential scanning calorimetry.  The 
effect of Ethocel® particle size and molecular weight on the drug release was investigated 
as was the influence of fine particle ethylcellulose on the physical stability of coated 
pellets and the physico-mechanical properties and water vapor permeability of sprayed 
films.  It was hypothesized that the addition of the substantially immiscible ethylcellulose 
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would decrease the degree of coalescence of the acrylic polymer and stabilize the drug 
release rate from coated pellets stored at both room and accelerated conditions. 
2.2.4 Investigate the Influence of Blends of Acrylic Polymers on the Physical Aging 
of Theophylline Pellets Coated with Eudragit® NE 30 D/RS 30 D 
The use of a plasticizer is necessary to decrease the glass transition temperature of 
a polymer, as well as lower the minimum film formation temperature.  The objective of 
this study was to investigate the effect of blending Eudragit® RS 30 D with Eudragit® NE 
30 D and examine the effect the polymer blend had on the drug release rate and physical 
stability of coated pellets.  The miscibility of the two polymers was examined as were the 
physico-mechanical properties and water vapor permeability of sprayed films.  It was 
hypothesized that the addition of Eudragit® RS 30 D would stabilize the drug release rate 
by increasing the glass transition temperature of the blend above storage conditions to the 
point that films would be formed and retain good physical stability during storage.   
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Chapter 3: An Investigation of the Use of Proteins to Minimize the 
Physical Aging of Eudragit® Sustained Release Films2 
Abstract: 
The objective of this study was to investigate the influence of two proteins, 
albumin and Type B gelatin, on the physical aging of Eudragit® RS 30 D and RL 30 D 
coated theophylline pellets. The physico-mechanical properties of sprayed films, thermal 
properties of cast films, influence of proteins on the zeta potential and particle size of the 
dispersion, and the release of proteins from cast films under simulated dissolution 
conditions were investigated.  The release rate of theophylline decreased significantly 
over time from pellets coated with an acrylic dispersion containing 10% albumin when 
there was no acidification of the acrylic dispersion; however, when pellets were coated 
with an acidified Eudragit®/albumin dispersion, the theophylline release rate was stable 
for dosage forms stored in the absence of humidity.  The drug release rate was faster for 
pellets coated with acrylic dispersions containing 10% gelatin compared to the albumin–
containing formulations.  When sprayed films were stored at 40°C/75% RH, the water 
vapor permeability decreased significantly for both Eudragit® films and those containing 
Eudragit® and albumin; however, there was no significant change in this parameter when 
10% gelatin was present.  Albumin was released from the acrylic films when the pH of 
the dissolution media was below the isoelectric point of the protein while no quantitative 
release of gelatin was observed in pH 1.2 or 7.4 media.  The effect of gelatin to prevent 
the decrease in drug release rate was due to stabilization in water vapor permeability of 
the film.  Acidification of the polymeric dispersion resulted in electrostatic repulsive 
forces between albumin and the acrylic polymer, which stabilized the drug release rate 
                                                 
2 Significant portions of this chapter were taken from: Kucera, S.A., W. Zheng, N. Shah, A. Malick, M. 
Infeld, and J.W. McGinity.  The Use of Proteins to Minimize the Physical Aging of Eudragit® Sustained 
Release Films.  Drug Dev. Ind. Pharm. 33 (7), pp. 717-726. (2007) 
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when the dosage forms were stored in aluminum induction sealed containers at both 
40°C/75% RH and 25°C/60% RH. 
3.1 INTRODUCTION 
The use of aqueous polymeric dispersions for film coating solid dosage forms has 
gained in popularity due to increased government regulations, as well as the safety issues 
associated with the use of organic solvents in film coating processes. The film formation 
mechanism, however, is more complex with latex and pseudolatex dispersions than with 
organic solvent systems. One problem prevalent in aqueous latex coating systems is 
physical aging of the polymeric film during storage.  This results from the further 
coalescence of latex particles and a decrease in void volume of the polymeric film as the 
polymer relaxes towards an equilibrium state [1-4].  Physical aging of film coatings will 
generally result in a decrease in the drug release rate from the coated dosage form [1, 2, 
4-7]. 
Diffusion-controlled drug release can be described by Fick's Law, as seen in 
equation 3.1, where Q is the quantity of drug released in time t, D is the diffusion 
coefficient of the drug, S is the area of diffusion, C1 is the drug concentration in the 




tCCDSQ )( 21−=                                                                                        (Eq. 3.1) 
 
τ
)(eDD w=                                                                                                    (Eq. 3.2) 
Fick's Law is related to physical aging by the Iyer equation, which is described by 
equation 3.2. Here, D is the diffusion coefficient of the drug, Dw is the diffusion 
coefficient of the drug in water, e is the film porosity, and τ is the film tortuosity.  There 
is a decrease in film porosity and void volume and an increase in tortuosity as 
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coalescence of the colloidal particles continues during storage, which results in a 
decrease in the diffusion coefficient. This decrease in the diffusion coefficient is 
responsible for the decrease in dissolution rate during storage of film coated dosage 
forms [7]. 
There have been several approaches published in the literature to prevent the 
physical aging of dosage forms coated with colloidal aqueous dispersions. Amighi and 
Moës [1] reported that as the plasticizer concentration was increased, the degree of 
coalescence of the latex particles also increased and that pellets coated with a polymeric 
dispersion containing less plasticizer showed more pronounced aging effects.  The time 
required to achieve a stabilized drug release rate was also dependent on the curing 
temperature, with stable films obtained faster when cured at higher temperatures.  
Maejima and McGinity [6] showed that thermal treatment along with high concentrations 
of micronized talc stabilized drug release from pellets coated with Eudragit® RS/RL 30 D 
plasticized with TEC.  The addition of a high glass transition temperature polymer to an 
acrylic dispersion to stabilize drug release rates was reported by Wu and McGinity [3].  
The addition of Eudragit® L 100-55 to Eudragit® RS 30 D resulted in a stable drug 
release rate in an acidic medium when coated pellets were stored under accelerated 
conditions. At a higher pH, an increase in drug release was seen due to pore formation as 
the enteric polymer dissolved.  Similarly, Eudragit® L 30 D-55 was shown to stabilize 
drug release from pellets coated with Eudragit® NE 30 D [4].  Inclusion of a hydrophilic 
polymer, hydroxyethylcellulose (HEC), to Eudragit® RS 30 D dispersions stabilized the 
drug release rates during storage due to the formation of an immiscible secondary phase 
surrounding the colloidal particles which interfered with further coalescence of the 
colloidal acrylic particles [7].  Lastly, ionic electrostatic interactions have also been 
investigated to minimize physical aging effects in aqueous-based polymeric dispersions 
[8]. 
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The objective of the present study was to investigate the influence of albumin and 
Type B gelatin on the physical aging of theophylline pellets coated with Eudragit® 
RS/RL 30 D.  The physico-mechanical properties of sprayed films, thermal properties of 
cast films, protein influences on the zeta potential and particle size of the dispersions, and 
the release of proteins from cast films under simulated dissolution conditions were 
investigated.  The effect of temperature and humidity during storage on drug release from 
coated pellets was studied as well as the influence of pH of the Eudragit® polymeric 
dispersion on protein-polymer interactions. 
3.2 MATERIALS AND METHODS 
3.2.1 Materials 
Eudragit® RS 30 D and RL 30 D dispersions were donated by Degussa 
(Parsippany, NJ, USA). Anhydrous theophylline, fraction V heat-shock bovine serum 
albumin (BSA), Type B gelatin, and lactose monohydrate were all purchased from 
Spectrum Chemical (Gardena, CA, USA). Polyvinylpyrrolidone (Kollidon® K-30) was 
donated by the BASF Corp. (Mount Olive, NJ, USA).  Microcrystalline cellulose 
(Avicel® PH-101) was donated by the FMC Corp. (Newark, DE, USA). Altalc 500V was 
supplied by Luzenac America, Inc. (Englewood, CO, USA). Triethyl citrate (TEC) was 
donated by Morflex, Inc. (Greensboro, NC, USA). Hypromellose (Pharmacoat® 603) was 
donated by Shin-Etsu Chemical Co. (Tokyo, JP). 
3.2.2 Methods 
3.2.2.1 Preparation of Core Pellets 
Anhydrous theophylline (25%), lactose monohydrate (45%) and microcrystalline 
cellulose (25%) were passed through a 30-mesh sieve and then mixed in a twin-shell 
blender for 15 minutes. A 12.5% w/v aqueous solution of polyvinylpyrrolidone 
(equivalent to 5% in the final formulation) was used as a binder in the wet-massing 
process. The wet mass was extruded using a LCI Benchtop Granulator (Tokyo, JP) at a 
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rotation blade speed of 50 rpm. The extrudates were spheronized at 1000 rpm for 2 
minutes using a Caleva Model 120 Spheronizer (Dorset, UK). The pellets were sieved 
after drying for 24 hours at 40°C, and the 16-20 mesh fraction was used for the coating 
trials. 
3.2.2.2 Preparation of Coating Dispersions 
Eudragit® RS 30 D (95% dry polymer weight) and Eudragit® RL 30 D (5% dry 
polymer weight) were combined with TEC (15%, based on the total dry polymer weight) 
and the protein solution (10%, based on the total dry polymer weight) and equilibrated 
with slow agitation for two hours under ambient conditions. Albumin was mixed with 
deionized water to yield a 3.75% solution prior to addition to the polymer dispersion. 
Gelatin was dissolved in deionized water (40°C) to yield a 1% solution and allowed to 
cool to room temperature before addition to the acrylic dispersion.  Talc (50%, based on 
the total dry polymer weight) was dispersed in 150 ml of deionized water using a 
POLYTRON (Brinkmann Instruments, Westbury, NY, USA) and then added to the 
acrylic dispersion for a further 15 minutes of agitation. 
3.2.2.3 Film Coating 
A 250-g batch containing 50% theophylline pellets and 50% non-pareils of the 
same size fraction was placed in a Strea-1 fluidized-bed coater (Aeromatic-Fielder, 
Bubendorf, SW), and the polymeric dispersion was applied with a peristaltic pump 
through a 1.2 mm nozzle until the film weight gain of the pellets was 15% theoretical 
gain. The inlet temperature was 40-42°C and the outlet temperature was 32-35°C.  To 
avoid pellet agglomeration, the dispersion was applied at a rate of 1 g/min until a weight 
gain of 2.5% had been reached and then increased to 3 g/min. The atomizing air pressure 
of the unit was 25 psi. The polymeric dispersion was stirred continuously throughout the 
coating process to prevent the sedimentation of the dispersed solids. 
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To prevent agglomeration and sticking of the pellets during storage, a 2% total 
weight gain of hypromellose (Pharmacoat® 603) was applied to the coated pellets from a 
5% w/w aqueous solution. The inlet temperature was 45°C, the outlet temperature 40°C, 
and the spray rate was 2 g/min.  The pellets were then placed in a 40°C oven for 12 hours 
to remove residual moisture. 
3.2.2.4 Free Film Preparation 
Films were prepared by either a cast or spray method.  For the cast method, the 
coating dispersion without talc was cast onto a Teflon plate and dried for 72 hours under 
ambient conditions.  These films were used in experiments to study protein release from 
films as well as for thermal experiments.  The second method to prepare the free films 
was a spray technique that was similar to a previously described method used by Obara 
and McGinity [9].  Films were sprayed onto a Teflon sheet attached to a cylinder rotating 
at 44 rpm. An infrared lamp was used to maintain the sprayed film in the temperature 
range of 22–28°C.  The atomizing air pressure was 0.50 kg/cm2. The spray rate was 
maintained at 2 g/min and delivered through the 1.2 mm nozzle. Formulations for the 
sprayed films were the same as those used in the coating trials. 
3.2.2.5 Thermal Analysis of Films 
The thermal properties of the cast films were determined by modulated 
differential scanning calorimetry (MDSC) (TA Instruments, New Castle, DE, USA). The 
films were cast from aqueous dispersions in the same ratios that were used for the film-
coating trials. Film samples of 10–15 mg were weighed into aluminum pans and then 
sealed. The samples were analyzed in a nitrogen atmosphere with a heating rate of 
3°C/min over a temperature range of -20–110°C with a modulation rate of 1°C/min. The 
glass transition temperature was determined as the midpoint of the transition using 
Modulated DSC Analysis V1.1A software. 
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3.2.2.6 Physico-Mechanical Testing 
Stress-strain experiments with films prepared by the spray method were 
performed using an Instron Model 4201 according to ASTM guideline D 882-02 [10]. 
Films were cut into 100 mm x 10 mm strips.  Thickness was measured using a Starrett® 
No. 723 digital micrometer (L.S. Starrett, Athol, MA) and the average of seven different 
measurements along the length of the film was determined.  A 1000 N load cell was 
mounted on the instrument. The distance between the grips was 60 mm, the load range 
was 50 N, and the crosshead speed was set at 10 mm/min. The tensile strength at break 
was determined. This parameter was calculated using the following formula: 
 
Area sectional-Cross Minimum
Break at LoadBreak at  StrengthTensile =                   (Eq. 3.3) 
 
3.2.2.7 Water Vapor Transmission Rate 
The water vapor transmission rate of the sprayed films was determined according 
to guidelines set forth in ASTM E 96-00 [11] using the desiccant method, as previously 
described by Zheng and McGinity [7].  The thickness of each film was determined using 
a Starrett® No. 723 digital micrometer (L.S. Starrett, Athol, MA) by measuring eight 
points along the circumference of a circular sample of sprayed film and averaging the 
values.  The film sample was secured to the open mouth of an aluminum permeability 
cup (4 cm inner diameter and 3 cm depth) containing 20 g of Drierite® desiccant.  The 
permeability cups were accurately weighed, placed in a humidity chamber at 23°C/80% 
RH, and periodically reweighed over seven days to determine the weight gain.  The water 
vapor transmission rate (WVT) and permeability (P) were calculated using the following 
equations [11]: 
 





WVTP ×−×= 21                                                                      (Eq. 3.5) 
where G is the weight change, t is the time during which G occurred, A is the test 
area (cup mouth area), S is the saturation vapor pressure at test temperature, R1 and R2 are 
the relative humidity in the test chamber and inside the cup, respectively, and d is the 
thickness of the film. 
3.2.2.8 Particle Size and Zeta Potential Analysis 
The particle size and zeta potential of the colloidal particles in the latex dispersion 
following the addition of either albumin or gelatin were determined using a Zeta Plus 
Zeta Potential Analyzer (Brookhaven Instruments Corp.).  The dispersion samples were 
diluted with deionized water, added to a cuvette, and allowed to stabilize at 25°C.  A 
refractive index of 1.59 was used for particle size studies. 
3.2.2.9 Viscosity Measurements 
The viscosity of the dispersions was measured using a Brookfield DV-I+ 
viscometer (Brookfield Engineering, USA) with an H1 spindle size at 30 ±1°C and 100 
rpm (n=3).  The viscosity of a 30% w/v Eudragit® RS/RL 30 D blend (95:5) was used as 
a control.  For measurements of albumin-containing dispersions, 10% protein (based on 
the dry polymer weight of the acrylic) was added as a solution while being stirred with a 
magnetic stir bar.  After all of the protein solution had been added, viscosity 
measurements proceeded and data was collected after 3 minutes. 
3.2.2.10 Protein Release from Free Films 
The dissolution rate of the protein from cast films containing either albumin or 
Type B gelatin was studied.  A 500 mg sample of cast film (containing approximately 40 
mg of protein) was placed in scintillation vials containing 20 ml of either pH 1.2 (0.1 N 
HCl) or pH 7.4 (50 mM) phosphate buffer previously heated to a temperature of 37°C. 
The vials were placed in an enclosed, temperature controlled (37°C) orbital shaker and 
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agitated at a rate of 100 rpm. Samples of 1 ml were removed at 1-, 3-, and 6-hour 
intervals. The protein assay was performed using a DC Protein Assay kit (BIO-RAD) 
with a reaction time of 15 minutes and a λmax of 750 nm using a µQuant 96-Well Plate 
Reader (Bio-Tek Instruments, Inc.). 
3.2.2.11 Stability Testing and In Vitro Drug Release 
Coated pellets were placed in polyethylene bottles and kept either open to the 
environment or hermetically sealed with aluminum induction seals with desiccant inside 
and then stored at 25°C/60% RH and 40°C/75% RH for up to 3 months.  The percent 
water absorbed from the coated pellets was analyzed by heating the pellets to 110°C for a 
period of 30 minutes using an AND MF-50 Moisture Analyzer (DSC, Inc., Encino, CA, 
USA).  Dissolution was performed according to the United States Pharmacopeia (USP) 
27 Apparatus II (Vankel VK 7000, Cary, NC, USA) over a 12-hour period in 900 ml of 
pH 7.4 (50 mM) phosphate buffer. The paddle speed was 50 rpm and the temperature of 
the media was maintained at 37±0.2°C. 
300 mg of coated pellets was added to each dissolution vessel and 5-ml samples 
were removed by a Vankel 8000 Autosampler (Cary, NC, USA) at 1-, 2-, 3-, 4-, 5-, 6-, 8-, 
10-, and 12-hour intervals. An infinity sample was obtained by mixing with a high-shear 
homogenizer (POLYTRON, Brinkmann Instruments, Westbury, NY, USA) and then 
analyzed for drug content. All dissolution tests were performed in triplicate. 
The theophylline content of each sample was analyzed using high performance 
liquid chromatography (HPLC). The samples were filtered through a 0.45 µm nylon 
filter. A volume of 4 ml was allowed to pass through the filter with the remaining 1 ml 
being used for analysis after filtration.  Analysis was performed using a Waters® 717 Plus 
Autosampler, two 515 HPLC pumps, a column heater set to 30°C, and 996 PDA. Results 
were calculated using Empower Pro software. A Metachem® Intertsil ODS-3 3 µm 
column (150 x 4.6 mm) was used for separation with an analyte retention time of 2.8 
minutes. The amount of theophylline released was computed by taking the analyte peak 
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area, comparing this to the peak area of the infinity time point sample, and multiplying by 
100 to obtain a percentage of theophylline released at each time point. 
3.3 RESULTS AND DISCUSSION 
The water vapor permeability of Eudragit® RS/RL 30 D sprayed films containing 
15% TEC and either 10% albumin or gelatin is shown in Table 3.1.  The films were 
stored at 40°C/75% RH in open containers.  When comparing initial values between the 
albumin and gelatin formulations, no significant difference was observed; however, there 
was a significant difference (single factor ANOVA, p<0.05) between the two protein-
containing formulations and the Eudragit® RS/RL 30D films. This difference was due to 
the hydrophilicity of the proteins.  During storage, a significant decrease in this parameter 
was seen in the Eudragit® RS/RL 30 D films as well as those containing albumin which 
was attributed to a decrease in void space and further densification of the film.  The films 
containing gelatin exhibited no significant change in water vapor permeability after 
storage and the significance of these results will become clear during the discussion of 
the results from the dissolution studies. 
The tensile strength of sprayed films stored for 1 month at 40°C/75% RH is also 
shown in Table 3.1.  Changes in tensile strength help explain the physical aging 
phenomenon in polymeric systems.  The further coalescence of polymeric latex particles 
causes an increase in tensile strength, which was reported in previous studies [7].  All 
films exhibited significant increases in tensile strength during storage. 
Plasticizers weaken polymeric intermolecular interactions and increase the 
flexibility of the polymer [12, 13], resulting in an increase in free-film elongation and a 
decrease in tensile strength.  A common method used to evaluate plasticizer effectiveness 
is by determination of the glass transition temperature (Tg).  The Tg was investigated to 
determine if plasticization would account for the mechanical changes observed in the 
protein-containing films.  The presence of either protein in the acrylic film showed no 
significant impact on the glass transition temperature in the presence or absence of 
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triethyl citrate, indicating that neither protein plasticized the acrylic polymer and that 
both proteins were immiscible with the polymer (Table 3.2).   
Monodisperse latex particles have previously been used to bind and separate 
albumin in biological applications [14].  This attraction was found to be due to the 
presence of hydrogen bonding between the latex particles and the albumin molecules. 
Since albumin is an amphoteric protein, the pH of the environment will determine the 
charge on the molecule.  At a pH above the isoelectric point of the protein, the molecule 
carries a net negative charge, while at a pH below the isoelectric point, albumin will carry 
a net positive charge.  Since the pH of the acrylic dispersion is in the range of 5.0-5.2 and 
the isoelectric point of albumin is 4.7 [15], Eudragit® RS/RL 30 D, which contains 
positively charged quaternary ammonium functional groups, will interact with the 
negatively charged albumin molecules and affect the film formation mechanism. 
During preparation of the coating dispersion, the acrylic dispersion exhibited a 
significant increase (single factor ANOVA, p<0.05) in viscosity from 16.57 (±1.07) cps 
to 56.67 (±1.62) cps when the albumin solution was added.  These findings were 
attributed to the agglomeration or binding between albumin and acrylic particles.  These 
results are supported by Omari and colleagues [8] who demonstrated that quaternary 
ammonium groups coupled with a chloride exhibit 100% dissociation of the chloride ion 
in the pH range of 1-8.  As these functional groups are positively charged, they are free to 
interact with negatively charged molecules in solution.  Particle size analysis was 
performed on an Eudragit® RS/RL 30 D dispersion adjusted to pH 2.5 by the addition of 
0.1 N HCl [16] and also at the pH of the dispersion as received (pH ≈ 5.0).  An increase 
in mean particle size of 40 nm (initial size 125 nm) was seen when albumin was added to 
the dispersion (pH≈5.0) while no increase in particle size was observed when albumin 
was placed in the pH 2.5 dispersion. 
The effect of protein addition on the zeta potential of the latex dispersion can be 
seen in Table 3.3.  The zeta potential is useful for determining how particles interact with 
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one another and for predicting the stability of dispersed colloid systems.  Inter-particle 
reactions are likely to occur when the particles are of a different charge, with these 
reactions mostly being coagulation [17].  The zeta potential of the Eudragit® dispersion in 
the current study was comparable to results reported by others [16]. When an albumin 
solution was added to the acrylic dispersion, however, a significant decrease in zeta 
potential was noted, indicating a decrease in colloidal stability.  At the lower pH, below 
the isoelectric point of albumin, colloidal stability was maintained as evidenced by no 
change in the zeta potential.  These findings were attributed to an electrostatic repulsion 
between the positively charged protein and the polymer.   
The influence of albumin on the theophylline release rate from coated pellets was 
studied.  When stored at 40°C and 75% relative humidity in open containers over three 
months, there was a significant decrease in drug release from pellets coated with an 
acrylic dispersion (pH≈5.0) containing albumin (Figure 3.1).  The drug release rate from 
the coated pellets had not equilibrated after three months of storage, and only 42% of the 
total theophylline was released after a period of 12 hours.  This decrease was in 
agreement with the changes observed in the physico-mechanical and water vapor 
permeability properties of the sprayed films as noted in Table 3.1.  When the pH of the 
Eudragit® dispersion was adjusted to 2.5 by the addition of 0.1 N HCl, a smaller decrease 
in drug release rate was observed during storage, but physical aging was still evident 
(Figure 3.2).  Albumin, being negatively charged at a pH above its isoelectric point, 
interacted with the acrylic polymer and depressed the drug release rate when compared 
with an acidified dispersion. 
When theophylline pellets coated with the acrylic-albumin dispersion were stored 
in hermetically sealed HDPE containers with desiccant, the coated pellets stored at 
40°C/75% RH (Figure 3.3) and 25°C/60% RH (Figure 3.4) showed no change in drug 
release over time.  The decrease in drug release rate seen in Figure 3.1 and Figure 3.2 was 
due to a combination of protein-polymer interaction and humidity causing a decrease in 
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the permeability of the film, rather than the temperature at which the dosage forms were 
stored.  The absorption of water due to highly humid storage environments has been 
shown to increase the physical aging of films [1, 3, 5, 18].  Water acts as a plasticizer and 
can cause further coalescence of the film during storage, leading to a decrease in drug 
release.  Both formulations containing 10% albumin and gelatin showed an increase in 
water content of 4.35% and 3.55%, respectively, during storage over 1 month at 40°C 
and 75% relative humidity in open containers. 
The addition of gelatin to the acrylic dispersion produced an opposite effect on 
drug release when compared to albumin.  As seen in Figure 3.5 and Figure 3.6, film-
coated dosage forms showed no change in the dissolution rate at 40°C and 75% relative 
humidity when stored in open containers and closed containers.  The complete 
coalescence of latex particles can only be achieved when polymeric molecules located at 
the interface between adjacent particles interpenetrate as a result of viscous flow. The 
addition of an immiscible hydrophilic polymer resulted in the formation of an 
incompatible phase around the colloidal latex particles, which prevented complete 
coalescence and interdiffusion of polymer chains [7].  Stabilization of drug release in the 
gelatin containing formulations can be explained by the water vapor permeability results 
which showed no change during storage after 1 month at 40°C/75% RH. 
The theophylline release was faster from pellets coated with an acrylic-gelatin 
dispersion in comparison to those coated with an acrylic-albumin dispersion.  One 
potential reason for these results may be related to pore formation in the film due to 
solvation of the protein during dissolution.  This was studied indirectly by investigating 
the amount of protein released in the media from cast films of Eudragit® RS/RL 30 D 
(95:5), 15% TEC, and either 10% albumin or Type B gelatin.  The release of albumin in 
the dissolution media was found to be a function of pH, as seen in Figure 3.7.  At a media 
pH of 1.2, albumin was released into the dissolution media.  The acidic environment 
changed the net charge of the albumin molecule to positive, resulting in albumin release 
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from the film due to charge-charge repulsion with the quaternary ammonium group of the 
acrylic polymer.  The drug release in 0.1 N HCl was faster with 100% of theophylline 
being released within 2-3 hours (data not shown).  At pH 7.4, a detectable amount of 
albumin was released in the dissolution media; however, this amount was below the 
limits of quantification in the assay used.  At this pH, the film was in an environment 
above the isoelectric point of the albumin, retaining the net negative charge and thus 
keeping the albumin bound to the acrylic polymer.  When latex films containing gelatin 
were investigated, the amount of gelatin free in solution was below the limits of detection 
at both pH 1.2 and 7.4.  These data show that gelatin did not dissolve to create pores 
through which theophylline would diffuse, but rather formed diffusional domains due to 
entanglement of the high molecular weight polypeptide with the acrylic polymer which 
altered the rate of diffusion of the drug through the membrane.  This is further supported 
by the lag time in drug release rate seen in Figure 3.1, Figure 3.2, Figure 3.3, and Figure 
3.4 and the increased rate of theophylline release seen in Figure 3.5 and Figure 3.6.  The 
acrylic latex is a copolymer of acrylic and methacrylic acid esters with hydrophilic 
quaternary ammonium groups, which are responsible for the polymer’s ability to swell 
when exposed to aqueous media [7].  The initial delay of drug release in formulations 
coated with acrylic-albumin dispersions shows that the polymer was the rate controlling 
membrane for drug release.  Conversely, the faster release of theophylline from gelatin-
containing formulations was due to the gelatin phase of the coating being responsible for 
the increase in the drug release rate. 
3.4 CONCLUSION 
The addition of 10% Type B gelatin to Eudragit® RS/RL 30 D films plasticized 
with 15% TEC stabilized theophylline release profiles, with no change in the release rate 
for pellets stored at 40°C and 75% relative humidity in both open and closed containers, 
with the mechanism being due to the stabilization of the water vapor permeability 
parameter.  The hydrophilic gelatin molecule resulted in films which exhibited a steady 
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water vapor transmission rate and faster release of the model drug from the coated dosage 
forms compared to those containing albumin.  The absence of gelatin in the dissolution 
media during protein release studies confirmed that the increase in drug release rate 
resulted from gel domains which facilitated diffusion of theophylline rather than the 
formation of pores in the film.  Complexation between albumin and the colloidal latex 
particles was due to changes in pH of both dispersion and dissolution media.  Humidity 
was a factor in the stability of theophylline pellets coated with albumin-containing acrylic 
dispersions.  A decrease in both the physico-mechanical properties and water vapor 
permeability of these films led to a decrease in theophylline release when stored in open 
containers at high humidity. 
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(g/Pa·s·m2) x 10-7 
TSB (106 Pa) 
Eudragit® RS/RL 30 D with 
15% TEC, t0 
2.28 ± 0.06 7.49 ± 0.31 
Eudragit® RS/RL 30 D with 
15% TEC, t1mo 
1.95 ± 0.06 7.95 ± 0.35 
Eudragit® RS/RL 30 D, 15% 
TEC, 10% Albumin, t0 
2.76 ± 0.19 4.91 ± 0.53 
Eudragit® RS/RL 30 D, 15% 
TEC, 10% Albumin, t1 mo. 
1.99 ± 0.19 9.09 ± 1.11 
Eudragit® RS/RL 30 D, 15% 
TEC, 10% Gelatin, t0 
2.74 ± 0.17 5.40 ± 0.77 
Eudragit® RS/RL 30 D, 15% 
TEC, 10% Gelatin, t1 mo. 
2.47 ± 0.17 14.12 ±  1.20 
NOTE:  Bolded values indicate no significant change when analyzed by single factor 
ANOVA with a p value of 0.05. 
Table 3.1 Effect of time on water vapor permeability (WVP) and tensile strength at break 
(TSB) of Eudragit® RS/RL 30 D films containing 15% TEC as a plasticizer 
and either 10% BSA or Type B Gelatin stored at 40°C/75% RH in open 




Formulation Tg (°C) 
Eudragit® RS/RL 52.08 
Eudragit® RS/RL 30D, 10% Albumin 54.12 
Eudragit® RS/RL 30D, 10% Type B Gelatin 51.87 
Eudragit® RS/RL 30D, 15% TEC 29.88 
Eudragit® RS/RL 30D, 15% TEC, 10% Albumin 31.17 
Eudragit® RS/RL 30D, 15% TEC, 10% Type B Gelatin 28.01 
Table 3.2 The effect of protein addition on the glass transition of Eudragit® RS/RL 30 D 





pH 5.2 pH 2.5 
Formulation 
ζ Potential (std. error) ζ Potential (std. error) 
Eudragit® RS/RL 30 D 48.35 (3.25) 49.70 (2.97) 
Eudragit® RS/RL 30 D containing 
10% Albumin 32.47 (2.51) 49.83 (1.93) 
Eudragit® RS/RL 30 D containing 
10% Type B Gelatin 49.63 (3.45) 46.75 (3.15) 
Table 3.3 The effect of protein addition on the ζ potential (in mV) of Eudragit® RS/RL 30 













Figure 3.1 The influence of albumin on the release of theophylline from pellets coated 
with Eudragit® RS/RL 30 D (15% W.G.) containing 10% albumin and 
stored at 40°C/75% RH in open containers (n=3). (Kucera, et al. Drug Dev. 





































Figure 3.2 The influence of dispersion pH (2.5) on the release of theophylline from 
pellets coated with Eudragit® RS/RL 30 D (15% WG) containing 10% 
albumin and stored at 40°C/75% RH in open containers (n=3). (Kucera, et 





































Figure 3.3 The influence of dispersion pH (2.5) on the release of theophylline from 
pellets coated with Eudragit® RS/RL 30 D (15% WG) containing 10% 
albumin and stored at 40°C/75% RH in hermetically sealed HDPE 
containers with desiccant (n=3). (Kucera, et al. Drug Dev. Ind. Pharm. Vol. 


































Figure 3.4 The influence of dispersion pH (2.5) on the release of theophylline from 
pellets coated with Eudragit® RS/RL 30 D (15% WG) containing 10% 
albumin and stored at 25°C/60% RH in hermetically sealed HDPE 
containers with desiccant (n=3). (Kucera, et al. Drug Dev. Ind. Pharm. Vol. 

































Figure 3.5 The effect of gelatin on the release of theophylline from pellets coated with 
Eudragit®  RS/RL 30 D containing 10% gelatin and stored at 40°C/75% RH 
in open and closed containers (n=3). (Kucera, et al. Drug Dev. Ind. Pharm. 
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Figure 3.6 The influence of dispersion pH (2.5) on the release of theophylline from 
pellets coated with Eudragit® RS/RL 30 D (15% WG) containing 10% 
gelatin and stored at 40°C/75% RH in hermetically sealed HDPE containers 




















































Figure 3.7 The effect of dissolution media pH on the release of albumin from Eudragit® 
RS/RL 30 D films plasticized with TEC (n=5). (Kucera, et al. Drug Dev. 





Chapter 4: A Study on the Influence of Fumed Silicon Dioxide on the 
Stabilization of Eudragit® RS/RL 30 D Film-Coated Theophylline 
Pellets3 
Abstract: 
The objective of this study was to investigate the influence of various grades of 
fumed silicon dioxide on the drug release rate and physical aging of Eudragit® RS 30 D 
and RL 30 D coated theophylline pellets. Free films were assessed for both physico-
mechanical properties and water vapor permeability with respect to time and storage 
conditions.  The release rate of theophylline was influenced by the physical properties of 
the silicon dioxide employed.  As the particle size of the silica dioxide decreased, there 
was an increase in dispersion viscosity, as well as a decrease in the theophylline release 
rate from the coated pellets.  Films prepared from formulas containing Aeroperl® 300 had 
twice the water vapor transmission rate of films prepared from formulas containing 
Aerosil® 200 VV and Cab-O-Sil® M-5P and showed consistent moisture permeability 
values during storage for up to 1 month at 25°C/0% RH.  SEM imaging of pellets coated 
with a formulation containing Aerosil® 200 VV or Cab-O-Sil® M-5P demonstrated film 
structures that were homogenous, while those coated with a formulation containing 
Aeroperl® 300 produced heterogeneous films with large particles of the excipient present 
within the polymeric matrix of the film.    Stability in the drug release rate exhibited by 
pellets coated with a formulation containing Eudragit® RS 30 D, 15% TEC, and 30% 
Aeroperl® 300 was attributed to the stabilization of the moisture vapor transmission rate 
of the acrylic films. Increasing the concentration of Aeroperl® 300 in the coating 
formulation increased the theophylline release rate from coated pellets. 
                                                 
3 Significant portions of this chapter were taken from: Kucera, S.A., D. Stimpel, N. Shah, A. Malick, M. 
Infeld, and J.W. McGinity.  The Influence of Fumed Silicon Dioxide on the Stabilization of Eudragit® 
RS/RL 30 D Film-Coated Theophylline Pellets.  Pharm. Dev. Tech. In Press.  (2008) 
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4.1 INTRODUCTION 
Film-coating with preparations of aqueous latex or pseudolatex dispersions has 
proven to be a popular method to manufacture sustained release dosage forms.  The 
mechanism of film formation from colloidal aqueous systems is very complex, with 
surface tension and capillary effects being the driving force of coalescence between latex 
particles [1-4].  These forces are due to water evaporating from the system and result in 
the interdiffusion of polymer chains.  A post-coat curing process, usually at temperatures 
above the glass transition temperature (Tg) of the polymer, is necessary to ensure that 
film formation is complete [5, 6].   Curing at temperatures that are too low or for an 
insufficient amount of time can result in products which are unstable due to continued 
coalescence of the latex particles during storage, resulting in a gradual decrease in drug 
release rates [1, 4, 7, 8].  As polymers undergo physical aging, there is a densification of 
the polymer which affects both the porosity and the tortuosity of the film [4, 9].  An 
increase in tortuosity coupled with a decrease in porosity will decrease the rate at which a 
drug permeates through the film.  Being that all polymers used in sustained release 
applications undergo physical aging, the pharmaceutical scientist must select an 
appropriate stabilization system for that particular polymer.  Previously, there have been 
several approaches to stabilize and prevent physical aging of film-coated dosage forms.  
These have included increasing the level of plasticizer in the film [1], utilizing high levels 
of talc [3], the addition of high Tg polymers [8, 10], the inclusion of immiscible polymers 
[4], and the addition of proteins [9]. 
An anti-adherent is a necessary component in a coating system to prevent sticking 
of the dosage forms during the manufacturing process.  Talc is the most common anti-
tack agent used in pharmaceutical applications and is usually present in concentrations of 
25-100% based on the dry polymer weight, although a previous report has described 
processes in which 200% talc was employed [3].  Drawbacks to using such high 
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concentrations of talc include sedimentation in the feed lines and clogging of the nozzle 
during coating.  Other researchers have reported that the use of glyceryl monostearate 
(GMS) at concentrations of 2-5% based on the dry polymer weight was sufficient as an 
anti-tack agent and was found to be superior to talc [11].  Colloidal silicon dioxide has 
also been used as an anti-tacking agent in film coating formulations [12].  Vecchio and 
coworkers reported that while there was a difference between the drug release rate from 
pellets coated with the very permeable Eudragit® RL 30 D and with a 80:20 blend of 
Eudragit® RL 30 D:Eudragit® RS 30 D when the formulation contained talc, no 
difference was found in the drug release rate between the two formulations when 
colloidal silicon dioxide was used.  When the amount of colloidal silica in the 
formulation was increased, there was a decrease in the drug release rate, reported to be 
due to an increase in the thickness of a gel layer formed by the high amount of colloidal 
silicon dioxide present in the formulation.  While the results of this investigation were 
interesting, no data were presented addressing the stability of the coated dosage forms. 
In the present study, the influence of particle size of fumed silicon dioxide on the 
drug release rate and physical stability of theophylline pellets coated with Eudragit® RS 
30 D and RL 30 D containing TEC as a plasticizer and either Cab-O-Sil® M-5P, Aerosil® 
200 VV, or Aeroperl® 300 was investigated.  It was hypothesized that the particles of 
colloidal silicon dioxide would act as a physical barrier to prevent the autoadhesion and 
further coalescence of the latex polymeric film during storage, resulting in acrylic-coated 
pellets that showed no change in drug release rate over time.  The effect of silicon 
dioxide on both the mechanical properties and the permeability of cast films was also 
studied.  The cross sectional morphology of coated pellets was investigated as well as the 
stability upon storage. 
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4.2 MATERIALS AND METHODS 
4.2.1 Materials 
Eudragit® RS 30 D and RL 30 D dispersions were donated by Degussa 
(Piscataway, NJ, USA). Triethyl citrate (TEC) was donated by Morflex, Inc. 
(Greensboro, NC, USA).  Anhydrous theophylline and lactose monohydrate were both 
purchased from Spectrum Chemical (Gardena, CA, USA). Polyvinylpyrrolidone 
(Kollidon® K-30) was donated by the BASF Corp. (Mount Olive, NJ, USA).  
Microcrystalline cellulose (Avicel® PH-101) was donated by the FMC Corp. (Newark, 
DE, USA).  Cab-O-Sil® M-5P was donated by the Cabot Corporation (Billerica, MA, 
USA).  Aerosil® 200 VV and Aeroperl® 300 were both donated by the Degussa 
Corporation (Piscataway, NJ, USA).  Imperial® 500 USP was generously donated by 
Luzenac America (Englewood, CO). 
4.2.2 Methods 
4.2.2.1 Preparation of Core Pellets 
Anhydrous theophylline (25%), lactose monohydrate (45%) and microcrystalline 
cellulose (25%) were passed through a 30-mesh sieve and then mixed in a twin-shell 
blender for 15 minutes. A 12.5% w/v aqueous solution of polyvinylpyrrolidone 
(equivalent to 5% in the final formulation) was used as a binder in the wet-massing 
process. The wet mass was extruded using an LCI Benchtop Granulator (Tokyo, JP) at a 
rotation blade speed of 50 rpm. The extrudates were spheronized at 1000 rpm for 2 
minutes using a Caleva Model 120 Spheronizer (Dorset, UK). The pellets were sieved 
after drying for 24 hours at 40°C, and the 16-20 mesh fraction was used for the coating 
trials. 
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4.2.2.2 Preparation of Coating Dispersions 
Eudragit® RS 30 D and Eudragit® RL 30 D were combined with TEC (15%, 
based on the total dry polymer weight) and equilibrated with slow agitation via magnetic 
stir bar for two hours under ambient conditions. Silicon dioxide was dispersed in water 
over a period of two minutes using a POLYTRON homogenizer (Brinkmann Instruments, 
Westbury, NY, USA).  The volume of the water was such that when the silica suspension 
was added to the acrylic dispersion, the coating formulation had total dispersed solids 
content of 15%.  The aqueous silica dispersion was then added to the Eudragit® acrylic 
dispersion for a further 10 minutes of agitation via magnetic stir bar. 
4.2.2.3 Film Coating 
A 250-g batch of pellets containing 50% theophylline pellets and 50% 16-18 
sugar spheres NF (Paulaur Corp., Cranbury, NJ, USA) was placed in a Strea-1 fluidized-
bed coater (Aeromatic-Fielder, Bubendorf, SW).  The sugar spheres were used to 
increase the volume of multi-particulates in the coating chamber during the process.  The 
cores were preheated for 10 minutes at 40°C before the application of the coating 
dispersion.  The dispersion was applied with a peristaltic pump through a 1.2 mm nozzle 
with an atomizing air pressure of 25 psi. The inlet temperature was 40-42°C and the 
outlet temperature was 32-35°C.  To avoid pellet agglomeration, the dispersion was 
applied at a rate of 1 g/min until a theoretical weight gain of 2.5% had been reached and 
then increased to 3 g/min. The polymeric dispersion was stirred continuously throughout 
the coating process to prevent the sedimentation of dispersed solids.  After coating, the 
pellets were dusted with 1.25 g of Imperial® 500 talc (0.5% based on the uncoated cores) 
and placed in a 40°C oven for 18 hours. 
4.2.2.4 Stability Testing and In Vitro Drug Release 
Coated pellets were placed in high density polyethylene containers which were 
hermetically sealed with aluminum induction seals with 1.0 g MINIPAX molecular sieve 
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(Impak Corporation, Los Angeles, CA) inside the container and then stored at 25°C/60% 
RH for up to 6 months.  Dissolution testing was performed according to the United States 
Pharmacopeia (USP) 29 Apparatus II (Vankel VK 7000, Cary, NC, USA) over a 12-hour 
period in 900 ml of pH 7.4 (50 mM) phosphate buffer. The paddle speed was 50 rpm and 
the temperature of the media was maintained at 37±0.2°C.   
300 mg of coated pellets (n=3) (containing 30 ± 3 mg API) were added to each 
dissolution vessel and 5-ml samples were removed by a Vankel 8000 Autosampler (Cary, 
NC, USA) after 1, 2, 3, 4, 5, 6, 8, 10, and 12 hours. An infinity sample was obtained by 
mixing with a high-shear homogenizer (POLYTRON, Brinkmann Instruments, 
Westbury, NY, USA) for 1.5 minutes and the aqueous media was then analyzed for drug 
content. All dissolution tests were performed in triplicate. 
The theophylline content of each sample was analyzed using ultraviolet (UV) 
spectroscopy.  A volume of 150 µL was taken from each sample and placed in a 
corresponding well of a Falcon 96-well UV transparent plate (VWR International, West 
Chester, PA, USA).  An equal volume of pH 7.4 dissolution media was added to each 
well to ensure that the concentrations were in the analytical range of the instrument.  The 
tray was then loaded in to a µQuant 96-Well Plate Reader (Bio-Tek Instruments, Inc., 
Winooski, VT, USA) and analyzed for theophylline at a wavelength of 273 nm.  The 
amount of theophylline released was calculated by taking the analyte concentration, 
comparing the value to the concentration of the infinity time point, and then multiplying 
by 100 to obtain a percentage of theophylline released at each time point. 
4.2.2.5 Free Film Preparation 
Films were prepared by using a casting method where either Eudragit® RS PO or 
Eudragit® RL PO was used in place of Eudragit® RS and RL 30 D, respectively.  An 
amount of 30% silicon dioxide (based on the dry polymer weight) was placed in a 
volume of acetone (which would give the final dispersion a polymer/silicon dioxide 
content of 15%) and homogenized for two minutes with a POLYTRON (Brinkmann 
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Instruments, Westbury, NY, USA) high-shear mixer.  TEC, at a concentration of 15% 
based on the dry polymer weight, was then added to the dispersion.  The Eudragit® 
polymer was then added to the acetone dispersion and stirred with a magnetic bar for a 
period of 15 minutes.  The resulting dispersion was separated into 50-ml fractions and 
cast into aluminum trays coated with BYTAC PTFE film (VWR International, 
Westchester, PA, USA).  The films were allowed to dry for a period of 24 hour under 
ambient conditions and then placed in a 40°C oven for a further 48 hours to facilitate 
solvent removal.  The films were allowed to equilibrate at 25°C/50% RH for 48 hours 
and then either tested for water vapor transmission rate or physico-mechanical properties, 
or stored at 25°C/0% RH for a period of up to 1 month to simulate pellet storage 
conditions. 
4.2.2.6 Physico-Mechanical Testing 
Stress-strain experiments with the cast films were performed using an Instron 
Model 4201 with a 1000 N load cell.  Prior to testing, films were cut into 70 mm x 15 
mm strips (n=5).  The thickness was measured using a Mitutoyo Model ID-C1012EBS 
digital micrometer (Mitutoyo Corp., JP) and the average of five different measurements 
along the length of the film was determined. Stress-strain measurements were conducted 
on the cut films in accordance with ASTM guideline D 882-02 [13] using a gap distance 
of 50 mm, load range of 1 N and crosshead speed of 25 mm/min.   The maximum tensile 
strength, percent elongation, and modulus of the films were calculated using Bluehill 
v.2.5 software. 
4.2.2.7 Water Vapor Transmission Rate 
The water vapor transmission rate of the cast films was determined according to 
guidelines set forth in ASTM E 96/E 96 – 05 [14] using the desiccant method.  The 
thickness of each film was determined using a Mitutoyo Model ID-C1012EBS digital 
micrometer by measuring four points along the circumference and one point at the center 
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of a circular sample of film and averaging the values.  The film sample was secured to the 
open mouth of an aluminum permeability cup (4 cm inner diameter and 3 cm depth) 
containing 20 g of Drierite® desiccant.  The permeability cups (n=3) were accurately 
weighed, placed in a humidity chamber at 23°C/80% RH, and periodically reweighed 
over 96 hours to determine the weight gain.  The water vapor transmission rate (WVT) 
and permeability (P) were calculated using the following equations: 
 




WVTP ×−×= 21                                                 (Eq. 4.2) 
where G is the weight change, t is the time during which G occurred, A is the test 
area (cup mouth area), S is the saturation vapor pressure at test temperature, R1 and R2 are 
the relative humidity in the test chamber and inside the cup (0% RH for the desiccant 
method), respectively, and d is the thickness of the film. 
4.2.2.8 Viscometry 
Vecchio and associates [12] reported a decrease in drug release rate when the 
amount of silicon dioxide in a coating formulation was increased and attributed this to a 
thicker, more viscous gel silicon dioxide being present during dissolution.  The viscosity 
of aqueous silicon dioxide dispersions was determined on fluids containing 6% w/w 
silicon dioxide.  To make the dispersion, 12 g of silicon dioxide was dispersed in 200 ml 
of water for a period of two minutes using a POLYTRON (Brinkmann Instruments, 
Westbury, NY, USA) high-shear mixer.  The dispersions were allowed to rest for five 
minutes and then the viscosity was measured using a Brookfield DV-I+ viscometer 
(Brookfield Engineering, USA) with an H1 spindle size at 30 ±1°C and 100 rpm (n=3). 
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4.2.2.9 Scanning Electron Microscopy 
Scanning electron microscopy (SEM) was used to study the cross-sectional 
morphology of the polymeric films in coated pellets.  The samples were mounted on an 
aluminum stage using carbon tape and coated for 45 seconds with gold-palladium in an 
argon environment using a Pelco®
 
Model 3 Sputter Coater (Ted Pella, Inc., Redding, 
CA).  Examination of the samples was carried out using a Hitachi S-4500 field emission 
microscope operating at an accelerating voltage of 5 kV.  Images were captured with 
Quartz® PCI software (Quartz Imaging Corporation, Vancouver, B.C. Canada). 
4.2.2.10 Statistical Treatments 
Statistical analysis of in vitro dissolution data was measured using the f2 similarity 
factor treatment described by Shah and associates [15].  To ensure that a bias in the f2 
similarity factor was not increased, only time points below 85% dissolution were utilized.  
MINITAB® Release 14 was used for the statistical analysis of the physico-mechanical 
properties and water vapor permeability of films using a one-way ANOVA with Tukey’s 
HSD test, α = 0.05. 
4.3 RESULTS AND DISCUSSION 
At the glass transition temperature of the polymer, the molecules are effectively 
locked in position in the polymeric glass, yet are free to rotate and translate until the 
lowest possible energy configuration is achieved [16].  These movements in the 
polymeric film result in a decrease in void volume of the film [1, 4-6], influencing both 
the tortuosity and the porosity.  These changes are often reflected by a decrease in the 
water vapor transmission rate of free films [4].  The water vapor permeability of cast 
films are shown in Figure 4.1.  A sample size of three films was tested initially after 
manufacturing, with the remaining films stored at 25°C/0% RH and tested after 1 week 
and after 1 month.  A comparison of the initial results showed that acrylic films 
containing Cab-O-Sil® M5P and Aerosil® 200 VV Pharma yielded similar permeabilities; 
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while the formulation containing the larger particle size of silicon dioxide (Aeroperl® 
300) had water vapor permeability values that were double those of the colloidal grade at 
the same time point.  Similar results were also reported by Okhamafe and York when 
investigating the permeability of hypromellose films containing talc and titanium dioxide 
[17].  They found a decrease in diffusion of water through the cellulosic membrane as the 
particle size of the additives decreased and the surface area of the insoluble excipients 
were increased.  Cast acrylic films containing 30% Aeroperl® 300 were found to exhibit 
stable water vapor transmission when stored for 1 month at 25°C/0% RH, while films 
containing Cab-O-Sil® M-5P and Aerosil® 200 VV exhibited decreases and increases, 
respectively, in this parameter.   
The physico-mechanical properties of films have been used to investigate the 
physical aging of polymers.  Densification of a polymeric film will result in an increase 
in both the elastic modulus and tensile strength and a decrease in the elongation of 
polymeric films.  The physico-mechanical properties of these films are reported in Table 
4.1.  Although those films containing Aeroperl® 300 showed no difference in modulus or 
tensile strength, there was a significant decrease in elongation, indicating physical aging 
in these systems.  Those films containing Cab-O-Sil® M-5P showed no increase in either 
maximum tensile strength or modulus.  Films that employed Aerosil® 200 VV exhibited a 
statistical increase in maximum tensile strength which could indicate physical aging in 
these systems.  When comparing the tensile strength of the films of the three different 
formulations, this parameter was found to be significantly lower for the formulation 
employing Aeroperl® 300.  Incorporation of the particles in the film can cause 
discontinuities in the network of the polymer matrix, resulting in a weak link in the 
structure of the film [18].  Thus, the presence of the large agglomerates of silicon dioxide 
in the films caused areas of shear stress which, in turn, affected the tensile strength of the 
film.  The films used to determine both the water vapor permeability and physico-
mechanical properties were manufactured via a solvent evaporation process, as opposed 
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to the films formed from the aqueous lattices used during the coating of multi-
particulates.  Care should be taken when attempting to extrapolate results from films 
formed by two different processes; however, it has been previously reported that films 
created from both aqueous and solvent methods aged in similar fashions when the 
physico-mechanical properties of said films were investigated [19]. 
The viscosity of silicon dioxide dispersion was found to depend upon the bulk 
density and secondary particle size of the silicon dioxide grade as seen in Figure 4.2.  
Cab-O-Sil® M-5P and Aerosil® 200 VV differ primarily in particle size and bulk density.  
While both grades have the same primary aggregate size of 150-300 nm, Aerosil® 200 
VV is mechanically compacted, giving it a larger secondary agglomerate size that only 
very high shear forces can break.  When comparing the two grades of silicon dioxide with 
particle sizes in the colloidal range, Cab-O-Sil® M-5P produced dispersions of the highest 
viscosity and also possessed the lowest bulk density value of 40 g/L, while Aerosil® 200 
VV possessed a lower viscosity and higher bulk density of 120 g/L.  These values 
indicate that the high shear forces imparted on the Aerosil® 200 VV when being 
dispersed in water were insufficient to break up the secondary agglomerates.  The 
granulated grade of silicon dioxide, Aeroperl® 300, had the lowest viscosity values and 
also the highest particle size (30 µm) and bulk density (280 g/L).   
Pellets were coated with a blend of Eudragit® RS 30 D: RL 30 D (95:5), 15% 
TEC as a plasticizer, and 30% silicon dioxide to a weight gain of 10% based on the dry 
polymer to investigate the influence of silicon dioxide on stabilizing the drug release rate 
from coated dosage forms after storage.  It was found that the grade of silicon dioxide 
used as a glidant in the coating formulation greatly influenced the theophylline release 
rate from coated pellets, as shown in Figure 4.3.  The drug release rate was proportional 
to the particle size and bulk density of the grade of silicon dioxide used in the coating 
formulation.  It was hypothesized that the decrease in drug release rate seen with the 
colloidal grades of silicon dioxide was due to viscous gel formation during dissolution 
 64
[12].  The cross-sectional morphology of coated pellets (Figure 4.4) demonstrated that the 
Aeroperl® 300 was still present as large agglomerates in the film coating surrounding the 
pellet.  These large agglomerates produced films of high permeability, as was confirmed 
in the water vapor permeability results reported in Figure 4.1.  Although not reflected in 
the water vapor permeability studies, pellets coated with the formulation containing 
Aerosil® 200 VV demonstrated a faster drug release rate than those coated with the 
formulation containing Cab-O-Sil® M-5P.  The cross-sectional morphology of the pellets 
showed that both grades produced dense, coherent film coatings with the coating 
containing Aerosil® 200 VV showing striations which would be indicative of the denser 
material present in its compacted form.  While there was a significant difference in the 
drug release profile between formulations using these two excipients, the variation 
between the permeability of films employing these two excipients during water vapor 
transmission studies was negligible.  During dissolution, the excipient is in intimate 
contact with water in the dissolution fluid, allowing for the hydration of the silicon 
dioxide which eases the diffusion of drug from the core.  The method used to measure the 
water vapor permeability of the films does not take into account the hydrophobicity of the 
polymer used in the film coating, explaining why films of different formulations could 
exhibit a permeability of the same magnitude, while pellets coated with the same 
formulations demonstrate dissimilar in vitro drug dissolution rates.  
Coated theophylline pellets that released ≥80% API after 12 hours were desired 
for a sustained release model system. Optimization of the drug release rate was 
performed for pellets coated with the formulations containing Aerosil® 200 VV, Cab-O-
Sil® M-5P, and Aeroperl® 300 (Table 4.2).  A blend of 90:10, Eudragit® RS 30 D: RL 30 
D, and 15% TEC offered drug release profiles that fit the requirements of the sustained 
release model system for formulations which contained 30% Cab-O-Sil® M-5P (Figure 
4.5) or Aerosil® 200 VV (Figure 4.6).  Increasing the fraction of highly permeable 
Eudragit® RL 30 D to 10%, compared to 5%, increased the drug release rate so that 
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between 85 and 90% of the drug was released after 12 hours when a weight gain of 15% 
(based on the dry polymer weight) was applied to the theophylline pellets.  The increase 
in release rate of theophylline from the formulation containing Aeroperl® 300 was 
mitigated by applying a 20% weight gain (based on the dry polymer weight) of poorly 
permeable Eudragit® RS 30 D with 15% TEC as a plasticizer (Figure 4.7).   
The coated pellets were stored in aluminum-induction sealed HDPE containers 
with desiccant at 25°C/60%RH.  The effect of storage for pellets coated with the 
formulation containing Cab-O-Sil® M-5P is depicted in Figure 4.5.     There was a small 
decrease in the drug release rate during storage of these dosage forms over time, which is 
consistent with the results from the water vapor permeability studies that demonstrated a 
decrease in the water vapor permeability during storage after 1 month at the same 
conditions (Figure 4.1).  When statistical analysis of dissolution data was performed 
between pellets after curing and those stored for 6 months, the f2 factor in the test for 
similarity was 64, indicating a slightly greater than 5% average change in theophylline 
release rate during storage (f2=65 indicates a 5% change).  The addition of 30% Aerosil® 
200 VV had the opposite effect on the stability of the drug release rate during storage.  
When stored at the same conditions for 6 months (Figure 4.6), there was an increase in 
drug release rate, which correlates to the increase in water vapor transmission rate of cast 
films discussed earlier.  The f2 similarity factor between the initial and 6 month sample 
was 62, representing an increase of slightly greater than 5% in the average drug release 
rate.  In contrast, the addition of 30% Aeroperl® 300 to the coating formulation was 
sufficient to stabilize the drug release rate from film-coated theophylline pellets during 
storage for 2 moths at 25°C/60% RH (Figure 4.7).  Dissolution profiles were super-
imposable over one another at 2 months, and an f2 value of 92 denoted an average 
variation of less than 2%.  Stabilization in the drug release rate from these coated pellets 
can be explained by the water vapor permeability results, which showed no change in this 
parameter during storage over one month at 25°C. 
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Vechhio and coworkers found that replacing talc with 30% colloidal silicon 
dioxide in the coating formulation increased the drug release rate when compared to 
pellets coated with an identical formulation in which 30% talc was used [12].  The 
authors also found that increasing the concentration of silicon dioxide from 30% to 60% 
decreased the drug release rate, presumably due to the formation of an increased gel layer 
which would serve to delay the release of drug from the coated dosage form.   In our 
studies, it was found that as the concentration of Aeroperl® in the coating formulation 
was increased, there was an increase in the drug release rate (Figure 4.8).  These results 
can be explained by examining the cross-sectional morphology of coated pellets as seen 
in Figure 4.4.  As the fraction of insoluble excipient was increased in the coating 
formulation, the coalescence of the acrylic polymer became interrupted by the presence 
of the large agglomerates of silicon dioxide.  The acrylic polymer functioned as a binding 
agent for the silicon dioxide, resulting in incomplete film formation and producing a film 
that became hydrated very quickly upon intimate contact with dissolution media.  This 
decrease in tortuosity of the film coating resulted in an increase in the theophylline 
release rate from coated pellets.  Maejima and coworkers showed the opposite effect 
when examining the influence of talc concentration on the stability and drug release rate 
of Eudragit® RS/RL 30 D coated theophylline pellets.  As the concentration of talc was 
increased from 50% to 100% (based on the dry polymer weight), there was a decrease in 
the permeability coefficient of the films and the polymeric weight gain needed to 
equalize the drug release rate was decreased for the higher level of talc [3].  These 
researchers found that although the acrylic polymer functioned as a binding agent for the 
talc, increasing concentrations of the hydrophobic excipient functioned to sustain the 
release of the drug during dissolution.  The effect of increasing the concentration of 
silicon dioxide was contrary to that of increasing talc concentration due to the large 
particle size and hydrophilicity of Aeroperl® 300 which increased membrane 
permeability and the hydrophobic nature of talc, which formed less permeable films. 
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4.4 CONCLUSIONS 
The rate of drug release was influenced by the grade of silicon dioxide used in the 
coating formulation.  Excipients with a particles size in the colloidal range resulted in 
dosage forms that showed a slower drug release profile, due to an enhanced incorporation 
of the smaller particle size silicon dioxide in the polymeric matrix of the film.  Increasing 
the concentration of Aeroperl® 300 in the coating formulation interrupted the coalescence 
of the acrylic polymers, creating films that were more permeable and final products that 
showed faster drug release rates. Increases and decreases in drug release rate from 
theophylline pellets coated with acrylic dispersions containing Aerosil® 200 VV and Cab-
O-Sil® M-5P, respectively, were due to instabilities in the water vapor permeability of 
these films; however, the difference in the drug release rate between the initial and 6-
month samples was about 5%. The addition of 30% Aeroperl® 300 to Eudragit® RS 30 D 
films plasticized with 15% TEC stabilized theophylline release profiles, with no 
significant change in the release rate for pellets stored at 25°C and 60% relative humidity 
in aluminum induction sealed HDPE containers. The stabilization in drug release was 
attributed to the permeability parameter of the acrylic film.   
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 Initial 1 Week 1 Month 
Cab-O-Sil® M-5P 143.64 ± 10.43 138.60 ± 5.36 127.75 ± 9.01 
Aerosil® 200 VV 136.92 ± 5.29 133.87 ± 6.20 136.45 ± 4.64 
Aeroperl® 300 147.11 ± 6.14 143.48 ± 7.56 139.89 ± 11.13 
Elongation at Break (%) 
 Initial 1 Week 1 Month 
Cab-O-Sil® M-5P 26.08 ± 5.84 31.89 ± 10.28 35.19 ± 5.74 
Aerosil® 200 VV 28.10 ± 6.21 26.84 ± 1.22 30.55 ± 3.61 
Aeroperl® 300 26.40 ± 6.75 36.36 ± 5.44 16.68 ± 1.07 
Tensile Strength at Max Load (MPa) 
 Initial 1 Week 1 Month 
Cab-O-Sil® M-5P 8.74 ± 0.21 9.37 ± 0.19 8.85 ± 0.34 
Aerosil® 200 VV 8.90 ± 0.47 10.04 ± 0.27 9.85 ± 0.04 
Aeroperl® 300 3.12 ± 0.38 2.77 ± 0.17 2.83 ± 0.21 
Table 4.1 The influence of time and temperature on the physico-mechanical properties of 
films containing 90:10 Eudragit® RS 30 D:RL 30 D, 15% TEC,  and either 
Cab-O-Sil® M-5P or Aerosil® 200 VV or Eudragit® RS 30 D, 15% TEC, 





Excipient 1 2 3 4 5 
Eudragit® RS 30 D (g) 123.75 123.75 183.33 183.33 183.33 
Eudragit® RL 30 D (g) 13.75 13.75 - - - 
TEC (g) 6.19 6.19 8.25 8.25 8.25 
Cab-O-Sil® M-5P (g) 12.38 - - - - 
Aerosil® 200 VV (g) - 12.38 - - - 
Aeroperl® 300 (g) - - 16.50 27.50 55.00 
Table 4.2 Composition of polymeric dispersions used in coating experiments (all diluted 
with water to 15% solids and adjusted for a 10% overage). (In Press, 

























Cab-O-Sil® M-5P Aerosil® 200 VV Pharma Aeroperl® 300
 
Figure 4.1 The effect of temperature and time on the water vapor permeability of cast 
films containing Eudragit® RS/RL 30D, 15% TEC and 30% silicon dioxide 






















Figure 4.2 The effect of silicon dioxide type on the viscosity of a 6% aqueous dispersion 















Figure 4.3 The influence of silicon dioxide type on the release of theophylline (30 mg) 
from pellets coated with Eudragit® RS 30 D:RL 30 D (95:5), 15% TEC, and 
30% silicon dioxide (  - Aeroperl® 300,  - Aerosil® 200 VV,  - Cab-O-
Sil® M-5P) (USP 29 Apparatus II, 900 ml pH 7.4 buffered phosphate 



























Figure 4.4 Scanning electron microscope cross-sections of pellets coated with silicon 
dioxide-containing formulations plasticized with TEC (a.) Eudragit® RS:RL 
30 D (90:10), 15% TEC, 30% Cab-O-Sil® M-5P; (b.) Eudragit® RS:RL 30 
D (90:10), 15% TEC, 30% Aerosil® 200 VV Pharma; (c.) Eudragit® RS 30 
D, 15% TEC, 30% Aeroperl® 300 (s=surface, f=film, p=pellet). (In Press, 























Figure 4.5 The influence of storage time on the release of theophylline (30 mg) from 
pellets coated with Eudrgit® RS/RL 30 D (90:10) containing 30% Cab-O-
Sil® M-5P and 15% TEC (Formulation 1) coated to a 15% weight gain and 
stored in sealed HDPE containers with desiccant at 25°C/60% (  - Initial, 
 - 1 Month,  - 2 Month,  - 3 Month,  - 6 Month) (USP 29 Apparatus 
II, 900 ml pH 7.4 buffered phosphate solution, 50 rpm, 37°C, n=3). (In 























Figure 4.6 The influence of storage time on the release of theophylline (30 mg) from 
pellets coated with Eudragit® RS/RL 30 D (90:10) containing 30% Aerosil® 
200 VV Pharma, 15% TEC (Formulation 2) and coated to a 15% weight 
gain and stored in sealed HDPE containers with desiccant at 25°C/60% RH  
(  - Initial,  - 1 Month,  - 2 Month,  - 3 Month,  - 6 Month) (USP 
29 Apparatus II, 900 ml pH 7.4 buffered phosphate solution, 50 rpm, 37°C, 























Figure 4.7 The influence of storage time on the release of theophylline (30 mg) from 
pellets coated with Eudragit® RS 30 D containing 30% Aeroperl® 300, 15% 
TEC (Formulation 3) and coated to a 20% weight gain and stored in sealed 
HDPE containers with desiccant at 25°C/60% RH (  - Initial,  - 1 Week, 
 - 2 Week,  - 1 Month,  - 2 Month) (USP 29 Apparatus II, 900 ml pH 
7.4 buffered phosphate solution, 50 rpm, 37°C, n=3). (In Press, 























Figure 4.8 Influence of Aeroperl® 300 concentration (based on dry polymer weight) on 
the release of theophylline from pellets coated (20% WG) with Eudragit® 
RS 30 D and 15% TEC (  - 100% (Formulation 5),  - 50% (Formulation 
4),  - 30% (Formulation 3)) (USP 29 Apparatus II, 900 ml pH 7.4 buffered 
phosphate solution, 50 rpm, 37°C, n=3). (In Press, Pharmaceutical 




Chapter 5: An Investigation of the Influence of Ethylcellulose Polymers 
on the Physical Stability of Theophylline Pellets Coated with Eudragit® 
NE 30 D4 
Abstract: 
The objective of this study was to investigate the influence of ethylcellulose (EC), 
a high glass transition temperature, non-enteric polymer, on the physical stability and 
drug release properties of theophylline from pellets coated with the poorly permeable, 
pH-independent, sustained release coating dispersion, Eudragit® NE 30 D.  The effect of 
EC addition on drug release from coated pellets, as well as the physico-mechanical, water 
vapor permeability, and thermal properties of sprayed films was investigated.  The 
particle size of EC, when mixed in a ratio of 1:1 with the acrylic polymer, affected the 
drug release rate, with those formulations possessing a smaller particle size exhibiting 
increased drug release rates.  When EC having a mean particle size of 9 µm was present 
in the acrylic films at a ratio of 1:2, 60% drug was released over 18 hours.  The drug 
release rate from these coated theophylline pellets was stable over 3 months at both 
25°C/60% RH and 40°C/75% RH when stored in aluminum induction sealed, high 
density polyethylene (HDPE) containers.  Sprayed films stored under the same conditions 
showed no change in the water vapor permeability and physico-mechanical properties.  
Modulated differential scanning calorimetry showed 3 transitions in the composite films, 
corresponding to the glass transition temperature of Eudragit® NE 30 D, ethylcellulose, 
and a third miscible phase.  This third miscible phase was determined to consist of 85% 
                                                 
4 Significant portions of this chapter were taken from: Kucera, S.A., C. Tessmann, N. Shah, A. Malick, M. 
Infeld, and J.W. McGinity.  The Influence of Ethylcellulose Polymers on the Physical Stability of 
Theophylline Pellets Coated with Eudragit® NE 30 D.  This paper is under review by the Journal of Drug 
Delivery Science and Technology. 
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The application of aqueous dispersions to solid oral dosage forms is one of the 
most common approaches to achieve sustained drug release in the body. The number of 
aqueous systems available for this application, however, is quite limited and all polymers 
used in sustained release applications have shown physical instabilities during storage [1-
3].  These instabilities can result in either an increase or decrease in the drug release rate 
over time as a function of both temperature and relative humidity. 
Eudragit® NE 30 D is an aqueous dispersion of a neutral copolymer based on 
ethyl acrylate and methyl methacrylate with neutral ester functionality and has previously 
been used as both a granulating agent [4-9] and a modified release film coating agent [10-
14].  The films formed from these dispersions are insoluble, poorly permeable, and 
exhibit pH-independent swelling during dissolution testing.  The polymer requires no 
additional plasticization due to its low Tg and forms films that are highly flexible with 
good compression properties. When sprayed onto solid oral dosage forms, this material 
forms a physical barrier to drug diffusion and the rate of drug release is controlled by the 
thickness of the membrane, with thicker films resulting in slower drug release rates. 
There have been reports in the scientific literature, however, of instabilities in 
drug release for dosage forms coated with this Eudragit® NE 30 D [2, 14].  Formulating 
with Eudragit® NE 30 D is further complicated by the fact that solid oral dosage forms 
can exhibit both increases and decreases in drug release rate as a function of time and 
storage conditions.  Decreases in drug release rate are seen during the initial swelling of 
the polymer and are due to the further gradual coalescence of the material during storage, 
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while increases in drug dissolution rate are due to the presence of endogenous excipient 
utilized in the preparation of the dispersion [15].  The polymeric dispersion is 
manufactured via emulsion polymerization with the use of nonoxynol 100 as a surfactant.  
Nonoxynol 100 has a relatively high melting point of about 65°C, which has been shown 
to crystallize in the films during storage at low temperatures [15, 16].  These crystals are 
water soluble and dissolve quickly during dissolution testing, forming pores in the 
coating and leading to faster drug release from aged samples. 
There is a paucity of research reported in the literature on stabilizing film-coated 
dosage forms employing Eudragit® NE 30 D.  Recently, the addition of a miscible, high 
Tg enteric polymer (Eudragit® L 30 D-55) to Eudragit® NE 30 D was shown to decrease 
the sticking of multi-particulate dosage forms during both coating and subsequent storage 
at elevated temperatures [14].  Over time, pellets coated with a blend of these two 
polymers also showed stable drug release rates in 0.1 N HCl after curing for 4 hours at 
60°C.  However, more research in stabilizing this sustained release polymer is needed. 
The objective of the present study was to investigate the effect of a high Tg non-
enteric polymer, Ethocel®, on the drug release rate and physical stability of theophylline 
pellets coated with Eudragit® NE 30 D.    It was hypothesized that the substantially 
immiscible, EC polymer would function to decrease the degree of coalescence of the 
acrylic polymer and stabilize the drug release rate of coated multi-particulates over time 
when stored at both ambient and accelerated conditions.  The effect of ethylcellulose 
particle size and molecular weight on the drug release rate of coated pellets was 
investigated.  The influence of fine particle ethylcellulose on the stabilization of drug 
release rates of coated pellets, the physico-mechanical properties, and the water vapor 
permeability of free films was also studied. 
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5.2 MATERIALS AND METHODS 
5.2.1 Materials 
Eudragit® NE 30 D dispersions were donated by Degussa, Röhm America 
(Piscataway, NJ, USA).  Ethocel® S4 and S7 FP cellulosic polymers were donated by 
Colorcon (West Point, PA, USA).  Anhydrous theophylline and lactose monohydrate 
were both purchased from Spectrum Chemical (Gardena, CA, USA). 
Polyvinylpyrrolidone (Kollidon® K-30) was donated by the BASF Corp. (Mount Olive, 
NJ, USA).  Microcrystalline cellulose (Avicel® PH-101) was donated by the FMC Corp. 
(Newark, DE, USA).  Imperial® 500 USP was donated by Luzenac America (Englewood, 
CO). 
5.2.2 Methods 
5.2.2.1 Preparation of Core Pellets 
Anhydrous theophylline (25%), lactose monohydrate (45%) and microcrystalline 
cellulose (25%) were passed through a 30-mesh sieve and then mixed 5 minutes. A 
12.5% w/v aqueous solution of polyvinylpyrrolidone (equivalent to 5% in the final 
formulation) was used as a binder in the wet-massing process. The wet mass was 
extruded using an LCI Benchtop Granulator (Tokyo, JP) at a rotation blade speed of 50 
rpm. The extrudates were spheronized at 1000 rpm for 2 minutes using a Caleva Model 
120 Spheronizer (Dorset, UK). The pellets were sieved after drying for 24 hours at 40°C 
and the 16-20 mesh fraction was used for the coating trials. 
5.2.2.2 Preparation of Coating Dispersions 
A quantity of ethylcellulose polymer was dispersed in water via high shear mixing 
with a POLYTRON® rotor-stator (Brinkmann Instruments, Westbury, NY, USA), added 
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to the Eudragit® NE 30 D dispersion, and agitated with a magnetic stir bar for a period of 
1 hour.  A quantity of Imperial® 500 talc equal to 50% of the dry polymer weight was 
then dispersed in a separate volume of water via high shear mixing with a POLYTRON®, 
added to the polymeric blend, and the resulting dispersion was allowed to mix for a 
further 10 minutes prior to application.  The final dispersion had a total solids content of 
15%.  The composition of the coating formulations is presented in Table 5.1. 
5.2.2.3 Coating of Theophylline Cores 
A 250-g batch of theophylline pellets was placed in a Strea-1 fluidized-bed coater 
(Aeromatic-Fielder, Bubendorf, SW).  The cores were preheated for 10 minutes at 30°C 
before coating dispersion was applied.  The dispersion was sprayed onto the pellets with 
a Watson-Marlow 520s peristaltic pump through a 1.2 mm nozzle with an atomizing air 
pressure of 25 psi. The inlet temperature was 29-30°C and the outlet temperature was 25-
27°C.  To avoid pellet agglomeration, the dispersion was applied at a rate of 1 g/min until 
a theoretical weight gain of 2.5% had been reached and the rate was then increased to 3 
g/min. The polymeric dispersion was stirred continuously throughout the coating process 
to prevent the sedimentation of dispersed solids.  After coating, the pellets were dusted 
with 1.25 g of Imperial® 500 talc (0.5% based on the uncoated cores) and placed in a 
60°C oven for 18 hours. 
5.2.2.4 Stability Testing and In Vitro Drug Release 
After curing at 60°C for 18 hours, the coated pellets were placed in aluminum 
induction-sealed high density polyethylene (HDPE) containers with a 1.0 g MINIPAX 
molecular sieve (Impak Corporation, Los Angeles, CA) inside the container and stored at 
25°C/60% RH or 40°C/75% RH for a period of up to 3 months.  Dissolution testing was 
performed according to the United States Pharmacopoeia (USP) 29 Apparatus II (Vankel 
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VK 7000, Cary, NC, USA) over a 18-hour period in 900 ml of pH 7.4 (50 mM) 
phosphate buffer. The paddle speed was 50 rpm and the temperature of the media was 
maintained at 37±0.2°C. 
Dissolution testing was performed in triplicate with 150 mg of coated pellets 
(containing 30 ± 3 mg theophylline) added to each dissolution vessel.  A volume of 5 ml 
was removed by a Vankel 8000 Autosampler (Cary, NC, USA) after 1, 2, 4, 6, 8, 10, 12, 
16, and 18 hours. Infinity samples were obtained by mixing with a high-shear 
homogenizer (POLYTRON®, Brinkmann Instruments, Westbury, NY, USA) for 1.5 
minutes. 
The theophylline content of each sample was analyzed using ultraviolet (UV) 
spectroscopy.  A volume of 150 µL was taken from each sample and placed in a 
corresponding well of a Falcon 96-well UV transparent plate (VWR International, West 
Chester, PA, USA).  An equal volume of pH 7.4 dissolution media was added to each 
well to ensure that the concentrations were within the analytical range of the instrument.  
The tray was then loaded into a µQuant 96-Well Plate Reader (Bio-Tek Instruments, Inc., 
Winooski, VT, USA) and analyzed for theophylline at a wavelength of 273 nm.  The 
amount of theophylline released was calculated by taking the analyte concentration, 
comparing this to the concentration of the infinity time point, and multiplying by 100 to 
obtain a percentage of theophylline released at each time point. 
5.2.2.5 Free Film Preparation 
Eudragit® NE 30 D films were formulated using a 1:1 weight of the polymer 
dispersion and water (75 g dispersion, 75 g water) to achieve a total solids content of 
15%.  For films containing Ethocel® 7 FP, the cellulosic polymer was added at a ratio that 
is half the dry polymer weight of Eudragit® NE 30 D and a volume of water was added to 
adjust the overall concentration of solids in the dispersion to 15% so that the resulting 
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films were composed of the same amount of Eudragit® NE 30 D polymer (e.g., to spray 
15 g of Eudragit® NE 30 D polymer, 150 g of dispersion was delivered).  The Ethocel® 7 
FP was dispersed in the water using a POLYTRON® for a period of 1 minute.  The 
dispersion was then added to the Eudragit® NE 30 D and allowed to stir for 1 hour prior 
to spraying. 
The dispersions were applied to a cylinder covered with Bytac® PTFE film 
rotating at 50 rpm via a Watson-Marlow 520s pump, marprene tubing, and a two fluid 
spray nozzle (Mini Hi-Coater, Vector Corporation, Marion, IA, USA).  The atomizing air 
pressure was set at 0.3 kg/m2 and the pump rate was 0.6 rpm (~1 g/min).  The spray 
apparatus provided an oscillatory motion over a 15 cm linear path at 28 rpm.  The 
distance from the nozzle to the rotating cylinder was 12 cm.  The temperature was 
controlled using two infrared heat lamps and set such that the surface of the film 
remained at a temperature of 25-30°C as measured by an infrared thermometer.  An 
amount of 100 g of the coating dispersion was used to create each Eudragit® NE 30 D 
film, while 150 g of the coating dispersion was used to create each Eudragit® NE 30 
D/Ethocel® 7 FP film.  After the spraying process was complete, the films were cured at a 
temperature of 60°C for a period of 18 hours.  The films were then removed from the 
oven and cut into geometries for either water vapor permeability trials (circular) or 
physical-mechanical testing trials (rectangular).  These films were then placed in 
desiccators and stored at 25°C or 40°C for stability studies.  The films were removed 
from the stability chambers and allowed to equilibrate at 25°C/50% RH for a period of 72 
hours prior to testing. 
5.2.2.6 Physico-Mechanical Testing 
Stress-strain experiments with the sprayed films were performed using an Instron 
Model 4201 with a 1000 N load cell.  Prior to testing, films were cut into 70 mm x 10 
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mm strips (n=10).  The thickness was measured using a Mitutoyo Model ID-C1012EBS 
digital micrometer (Mitutoyo Corp., JP) and the average of five different measurements 
along the length of the film was determined. Stress-strain measurements were conducted 
on the cut films in accordance with ASTM guideline D 882-02 [17] using a gap distance 
of 50 mm, load range of 1N and crosshead speed of 25 mm/min.   The maximum tensile 
strength, percent elongation, and modulus of the films were calculated using Bluehill 
v.2.5 software (Instron, Norwood, MA). 
5.2.2.7 Water Vapor Permeability Testing 
The water vapor permeability of the sprayed films was determined according to 
guidelines set forth in ASTM E 96/E 96 - 05 using the desiccant method [18].  The 
thickness of each film was determined using a Mitutoyo Model ID-C1012EBS digital 
micrometer by measuring four points along the circumference and one point at the center 
of a circular sample of film and averaging the values.  The film sample was secured to the 
open mouth of an aluminum permeability cup (4 cm inner diameter and 3 cm depth) 
containing 20 g of Drierite® desiccant.  The permeability cups (n=3) were accurately 
weighed, placed in a humidity chamber at 23°C/80% RH, and periodically reweighed 
over 96 hours to determine the weight gain.  The water vapor transmission rate (WVT) 
and permeability (P) were calculated using the following equations [18]: 
 




WVTP ×−×= 21                (Eq. 5.2) 
where G is the weight change, t is the time during which G occurred, A is the test 
area (cup mouth area), S is the saturation vapor pressure at test temperature, R1 and R2 are 
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the relative humidity in the test chamber and inside the cup (0% RH for the desiccant 
method), respectively, and d is the thickness of the film. 
5.2.2.7 Particle Sizing of Ethylcellulose Powders 
The particle size of Ethocel® powders used in the coating formulations were 
determined using a Malvern Mastersizer® 2000 (Malvern Instruments, Ltd., 
Worcestershire, UK) with water as the dispersing medium.  A nominal amount of 
ethylcellulose powder was dispersed in deionized water by shaking in a scintillation vial.  
The dispersion was then added to the apparatus, with recirculation and sonication, until a 
percent obscurance of between 15% and 30% was acquired.  The particle size was 
reported as the D(v, 0.5). 
5.2.2.8 Determination of Thermal Properties 
The thermal properties of sprayed films were determined using modulated 
differential scanning calorimetry (MDSC) via a DSC 2920 (TA Instruments, New Castle, 
DE, USA).  Film samples of 5-10 mg were weighed into aluminum pans and then sealed.  
The samples were analyzed over a range of -20-180°C with a nitrogen flow rate of 40 
ml/min, a heating rate of 12°C/min, and a modulation rate of 0.5°C with a period of 40 
seconds.   The glass transition temperature (Tg) was determined as the midpoint of the 
transition using Modulated DSC Analysis V 1.1A software. 
5.2.2.9 Scanning Electron Microscopy 
To investigate the effect of dissolution media on the surface morphology of the 
dosage forms, pellets coated with either Eudragit® NE 30 D or a 2:1 ratio of Eudragit® 
NE 30 D:Ethocel® 7 FP were placed in 900 ml of pH 7.4 (50 mM phosphate) buffered 
solution and agitated via USP Apparatus II with a paddle rotation speed of 50 rpm and 
temperature held constant at 37.2°C.  After 3 hours, the pellets were separated from the 
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media with a 100 µm screen and washed with deionized water.  The pellets were then 
placed in a chamber containing desiccant (calcium sulfate) under vacuum for a period of 
48 hours.  To examine pellets that had not undergone dissolution, the pellets were placed 
on a 100 µm screen and washed briefly with deionized water to remove any talc that may 
have adhered to the surface.  These pellets were also placed in the desiccated chamber 
under vacuum for a period of 48 hours.  The pellets were secured to an aluminum stage 
with the use of adhesive carbon tape and coated with gold for 45 seconds in an argon 
atmosphere.  Observation of the surface morphology of the pellets was carried out with 
the use of Hitachi S-4500 field emission scanning electron microscope. 
5.2.2.10 Statistical Analysis 
Statistical analysis of in vitro dissolution data was measured using the f2 similarity 
factor treatment described by Shah, et al. [19].  To ensure that a bias in the f2 similarity 
factor was not increased, only one time point above 85% dissolution was utilized, when 
applicable. 
Statistical evaluation of the physico-mechanical properties and water vapor 
permeability of sprayed films was conducted with Minitab Release 14 software using 
both the Kruskal-Wallis test (non-parametric, α=0.05) and the one-way analysis of 
variance (ANOVA) with α=0.05 for a 95% confidence level and Tukey’s HSD post hoc 
test was used to compare the means of each population. 
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5.3 RESULTS AND DISCUSSION 
The effect of particle size of Ethocel® S4 on the release rate of theophylline from 
pellets coated with a 1:1 aqueous dispersion of Eudragit® NE 30 D:Ethocel® S4  blend 
(Formulations B and C) is shown in Figure 5.1.  It can be seen that as the particle size of 
Ethocel® S4 decreases from 91 µm to 39 µm, the rate at which theophylline was released 
from the coated pellets increased.  Similar increases in film permeability were also 
reported by Parker [20] and co-workers when investigating the effect of talc particle size 
on the water vapor permeability of free films.  The researchers found that as the particle 
size of talc decreased, there was an increase in the permeability of films to moisture.  
Maul and Schmidt [21] also showed that particle size and morphology of pigments 
influenced the dissolution rate of bisacodyl from pellets coated with Eudragit® L 30 D.  It 
was found that large, platelet-like additives functioned to decrease the drug release rate 
when compared to smaller, spherical-shaped particles.   Since the size fractions of 
Ethocel® S4 were 91 µm and 39 µm, it was deemed impractical to continue coating 
studies with this excipient, as the large particle size of this grade of Ethocel® could 
interrupt the interfacial bonding between the polymer and the surface of the coated pellet 
[22]. Subsequent studies utilized Ethocel® 7 FP, which had a particle size range of 5-15 
µm, with a mean particle size of 9 µm.  It was expected that the small particle size of the 
Ethocel® 7 FP would further increase the drug release rate if pellets were coated with a 
formulation of 1:1 Eudragit® NE 30 D:Ethocel® 7 FP; thus, the remaining coating trials 
were carried out with a formulation of 2:1 Eudragit® NE 30 D:Ethocel® 7 FP. 
The effect of Ethocel® 7 FP on the thermal properties of Eudragit® NE 30 D 
sprayed films was investigated using modulated differential scanning calorimetry 
(MDSC), and the results are shown in Figure 5.2.  The glass transition temperature of 
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Eudragit® NE 30 D free films alone (curve a) was found to be 12.9°C, which was in close 
agreement with the glass transition temperature of 11°C reported by the manufacturer 
[23]. The glass transition temperature of Ethocel® 7 FP powder (curve c) was determined 
to be 127.8°C, which was in close agreement with previously reported values of 129-
133°C [24].  When the thermal properties of 2:1 Eudragit® NE 30 D:Ethocel® 7 FP free 
films (curve b) were examined, the glass transition temperatures of both the acrylic and 
cellulosic polymers were prominent and relatively unchanged, as was the melting point 
endotherm of nonoxynol 100 at 47.12°C; however, a third thermal event was also 
observed at 103.12°C.  Previously published Hansen solubility parameters for Eudragit® 
NE 30 D and ethylcellulose have demonstrated values of 17.1 MPa1/2 [23] and 20-21 
MPa1/2 [25, 26], respectively.  Solubility parameters have previously been used to 
characterize component miscibility, and differences less than 7.0 MPa1/2 were shown to 
indicate miscibility of components [27].  This suggested that the third thermal event in 
the MDSC thermogram was a phase consisting of the acrylic and cellulosic polymer. 
The Gordon-Taylor equation (equation 5.3) [28] has been used in previous studies 
to determine the glass transition temperature of miscible polymer blends [29], and was 
applied here to calculate the composition of the third phase in the film with Tg12 defined 
as the glass transition of the thermal event, w1 and Tg1 being the weight fraction and glass 
transition temperature of the material with the lower glass transition temperature, w2 and 
Tg2 being the weight fraction and glass transition temperature of the material with the 












=                                                                                 (Eq. 5.3) 
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Assuming that the fraction of nonoxynol 100 in the film is negligible, the third 
phase is composed of only ethylcellulose and the acrylic polymer such that: 
 















=                                    (Eq. 5.5) 
and 
21 1 ww −=                             (Eq. 5.6) 
When the data from thermal analysis were applied to this equation, it was found 
that this third phase was composed of 85% ethylcellulose and 15% acrylic polymer; 
however, this third phase was determined to be a small fraction of the overall 
composition by evaluation of the specific heat profile, suggesting that the two polymers 
were substantially immiscible. 
Physico-mechanical properties have been reported in the literature to investigate 
the aging phenomena of polymeric films [30-33].  Further coalescence and inter-diffusion 
of the polymer chains during storage results in decreased elongation and increased 
modulus of the films [33].  When investigating the physico-mechanical properties of 
sprayed films containing a 2:1 blend of Eudragit® NE 30 D:Ethocel® 7 FP, there was no 
statistically significant change in either elongation (Figure 5.3(a)) or modulus (Figure 
5.3(b)), indicating that further coalescence of the acrylic polymer was hindered by the 
presence of the fine particle ethylcellulose.  Analysis of moduli by ANOVA gave p-
values of 0.234 and 0.328 for films stored at 25°C and 40°C, respectively; while analysis 
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of moduli via non-parametric methods (Kruskal-Wallis) gave p-values of 0.089 and 0.098 
for films stored at 25°C and 40°C, respectively. 
 Physical aging of polymers can also produce changes in the permeability of free 
films [32, 33].  Decreases in this parameter are due to changes in both porosity and 
tortuosity of the polymer, indicating densification of the film.  The data presented in 
Figure 5.4  show that films composed of Eudragit® NE 30 D:Ethocel® 7 FP (2:1) 
exhibited a higher permeability than films of Eudragit® NE 30 D alone at the initial time 
point, indicating that the films containing ethylcellulose were more permeable.  The films 
containing the blend of Eudragit® NE 30 D and Ethocel® 7 FP, when stored at 25°C for a 
period of up to 1 month, showed no statistical change in permeability from the initial 
values (p = 0.089 for ANOVA, p=0.108 for Kruskal-Wallis)  and indicated that the films 
were stable.  The decrease in permeability seen in films of the same composition stored at 
40°C was statistically significant (p=0.002 for ANOVA, p=0.024 for Kruskal-Wallis); 
however, the magnitude of change was very small when compared to those films 
consisting of only Eudragit® NE 30 D which had been stored at 40°C.  Thus, it was 
expected that any variations observed in the dissolution rate of theophylline pellets coated 
with a blend of the acrylic and cellulosic polymer stored at these conditions would be 
minimal. 
The application of a 7.5% weight gain of Eudragit® NE 30 D (Formulation A) to 
the theophylline pellets resulted in less than 20% drug dissolution in pH 7.4 (50 mM 
phosphate) buffer during 18 hours of dissolution.  The addition of 50% Ethocel® 7 FP 
(based on the dry polymer weight of the acrylic) (Formulation D) significantly increased 
the drug dissolution rate so that approximately 60% theophylline was released at the 18 
hour time point (Figure 5.5) and resulted in a zero-order drug release profile.  Both 
formulations have the same amount of Eudragit® NE 30 D applied to the dosage forms, 
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with those containing Eudragit® NE 30 D having a 7.5 % total polymer weight gain and 
those containing Ethocel® having a total polymer weight gain (the sum of the acrylic and 
cellulosic polymers) of 15%.  This increase in drug dissolution rate was due to the 
formation of channels in the films of coated dosage forms as seen in Figure 5.6.  The 
scanning electron micrographs in Figure 5.6(a) and Figure 5.6(c) show the surface 
morphology of film-coated theophylline pellets before dissolution testing.  Both pellets 
exhibit smooth surfaces prior to testing; the plate-like particles on the surface were 
identified as talc, which was added to prevent the sticking of the pellets during coating.  
There was a noticeable change between the two formulations following dissolution.  The 
pellets coated with only Eudragit® NE 30 D (Figure 5.6(d)) continued to exhibit a smooth 
surface, while those coated with a formulation containing Ethocel® 7 FP (Figure 5.6(b)) 
showed the formation of pores and channels, which served to increase the dissolution of 
theophylline from the drug containing core.  The increase in drug release rate 
corresponded well with the enhanced permeability of sprayed films noted from the water 
vapor permeability studies. 
The stability (with respect to drug release rate) of coated pellets was determined 
by placing the dosage forms in aluminum induction sealed HDPE containers with 
desiccant at storage conditions of both 25°C/60% RH (Figure 5.7) and 40°C/75% RH 
(Figure 5.8).  When the pellets were stored at the lower temperature, the theophylline 
release rate was stable over the course of 3 months, with an f2 similarity factor of 85.  
Likewise, when stored at 40°C/75% RH the drug release rate was also stable, with an f2 
similarity factor of 81.  The water vapor permeability studies of sprayed films showed a 
small decrease in the permeability for Eudragit® NE 30 D: Ethocel® 7 FP films stored at 
40°C; however, as expected, a decrease in drug release rate was not observed in the film-
coated dosage forms.  
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5.4 CONCLUSIONS 
The rate of drug release was found to be influenced by the particle size of EC 
used in the coating formulations, with the smaller particle size creating more permeable 
films and a faster drug release rate.  The investigation of thermal data indicated a minimal 
amount of miscibility between the two polymers, with this miscible phase occupying only 
a small part of the overall composite.  Scanning electron microscopy confirmed the 
presence of pores and channels in the film during dissolution which allowed drug 
molecules to easily diffuse through the coating.  Stabilization of the drug release rate 
from the coated dosage forms was attributed to constant water vapor permeability values 
and maintenance of the physico-mechanical properties of sprayed films.  The results from 
this study suggest that the addition of fine particle ethylcellulose prevents the 
densification and further coalescence of the acrylic polymer at conditions where were 
significantly above the glass transition temperature.   
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Formulation A B C D 
Eudragit® NE 30 D 68.75 68.75 68.75 68.75 
Ethocel® S4 0 20.63 20.63 0 
Ethocel® S7 FP 0 0 0 10.31 
Imperial® 500 10.31 20.63 20.63 15.47 
Water 127.19 302.5 302.5 214.84 
Total 206.25 412.51 412.51 309.37 
Table 5.1 Composition of polymeric dispersions used in coating experiments (all diluted 
























Figure 5.1 The influence of Ethocel® S4 particle size (▲ - 39 µm,  - 91 µm) on the 
release of theophylline from pellets coated with a 15% weight gain of 
Eudragit® NE 30 D:Ethocel® S4 (1:1) and 50% Imperial® 500 talc  (USP 29 



















Figure 5.2 Modulated differential scanning calorimetry (MDSC) thermograms of (a.) 
Eudragit® NE 30 D; (b.) Eudragit® NE 30 D:Ethocel® 7 FP (2:1); (c.) 





































Figure 5.3 The influence of time and temperature on the physico-mechanical properties 
of sprayed films containing Eudragit® NE 30 D:Ethocel® 7 FP (2:1), (a.) % 



























Figure 5.4 The effect of temperature and time on the water vapor permeability of sprayed 
films containing Eudragit® NE 30 D:Ethocel® 7 FP (2:1) ( ,  25°C, , 























Figure 5.5 The influence of Ethocel® 7 FP addition on the release of theophylline from 
coated pellets (  - Eudragit® NE 30 D:Ethocel 7 FP (2:1), 50% Imperial® 
500 talc, 15% W.G.;  - Eudragit® NE 30 D, 50% Imperial® 500 talc, 7.5% 
W.G.) (USP 29 Apparatus II, 900 ml pH 7.4 buffered phosphate solution, 50 



















Figure 5.6 Scanning electron micrographs of pellets coated with Eudragit® NE 30 
D:Ethocel® 7 FP (2:1): (a.) before dissolution, (b.) after 3 hours dissolution; 
and pellets coated with Eudragit® NE 30 D: (c.) before dissolution, (d.) after 
3 hours dissolution. (USP 29 Apparatus II, 900 ml pH 7.4 buffered 

























Figure 5.7 The influence of storage time on the release of theophylline (30 mg) from 
pellets coated with Eudragit® NE 30 D:Ethocel® 7 FP (2:1) and 50% 
Imperial® 500 talc coated to a 15% weight gain and stored in sealed HDPE 
containers with desiccant at 25°C/60% RH (  - initial,  - 2 week,  - 1 
month, ▲ – 3 month)(USP 29 Apparatus II, 900 ml pH 7.4 buffered 























Figure 5.8 The influence of storage time on the release of theophylline (30 mg) from 
pellets coated with Eudragit® NE 30 D:Ethocel® 7 FP (2:1) and 50% 
Imperial® 500 talc coated to a 15% weight gain and stored in sealed HDPE 
containers with desiccant at 40°C/75% RH (  - initial,  - 1 month,  - 2 
month, ▲ – 3 month)(USP 29 Apparatus II, 900 ml pH 7.4 buffered 
phosphate solution, 50 rpm, 37°C, n=3). 
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Chapter 6: Influence of an Acrylic Polymer Blend on the Physical 
Stability of Film-Coated Theophylline Pellets 
Abstract: 
The purpose of this study was to investigate the physical stability of a coating 
system consisting of a blend of two sustained-release acrylic polymers and its influence 
on the drug release rate of theophylline from coated pellets.  Eudragit® RS 30 D was 
plasticized by the addition of Eudragit® NE 30 D and the predicted glass transition 
temperature (Tg) of the blend was similar to the experimental values.  Sprayed films 
composed of a blend of Eudragit® NE 30 D:Eudragit® RS 30 D (1:1) showed a water 
vapor permeability value six times greater than those films containing only Eudragit® NE 
30 D due to the presence of quaternary ammonium functional groups that increased the 
swellability of the polymer blend.  The films prepared from the blend exhibited stable 
permeability values when stored for 1 month at both 25°C and 40°C, while the films 
which were composed of only Eudragit® NE 30 D showed a statistically significant 
decrease in this parameter when stored under the same conditions.  Eudragit® NE 30 
D:Eudragit® RS 30 D (1:1) sprayed films decreased in elongation from 180% to 40% 
after storage at 40°C for  1 month, while those stored at 25°C showed no change in 
elongation during the same study.  In coated pellets, the addition of Eudragit® RS 30 D to 
the Eudragit® NE 30 D increased the theophylline release rate and the pellets were stable 
when stored at 25°C for a period of up to 3 months due to maintenance of the physico-
mechanical elongation of the film.   Those pellets stored at 40°C exhibited a decrease in 
drug release rate over time as a result of changes in film physico-mechanical properties 
which was attributed to further coalescence and densification of the polymer.  When 
storage conditions were above the Tg of the composite, instabilities in both drug release 
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rate and physical properties were evident.  Stabilization in drug release rate from coated 
pellets could be correlated with the physico-mechanical stability of the film formulation 
when stored at temperatures below the Tg of the polymer.  
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6.1 INTRODUCTION 
The coating of dosage forms with aqueous latex or pseudolatex dispersions is a 
common manufacturing process utilized in designing sustained release dosage forms.  
Both acrylic- and cellulosic-based polymer systems have been used as excipients for 
modified release coatings in this regard.  While the use of these aqueous coating systems 
is advantageous in some respect, both systems have inherent problems in that films 
formed by these polymers can undergo an aging process, resulting in physically unstable 
films as a function of time, temperature, and relative humidity [1-5].   
The physical aging of polymeric films is a problem that both polymer scientists 
and chemical engineers have been aware of for many years.  Struik [6] has reported that 
the driving force for aging in amorphous polymers is the movement towards a 
thermodynamic equilibrium.  As a result of being essentially “locked” in place at 
temperatures below the glass transition temperature (Tg) of the material, the polymer 
possesses an enthalpy and free volume that is much greater than at equilibrium.  Since the 
molecular mobility of the polymer is not zero, the free volume of the material will 
continue to decrease slowly over time until equilibrium is reached.  This densification of 
the polymer results in changes in the diffusivity of the membrane. 
Drug release from pellets coated with insoluble polymers follows Fick’s First 
Law of Diffusion, as seen in equation 6.1, where Q is the amount of drug that has 
diffused through the film as a function of time t, h is the thickness of the film, D is the 
diffusion coefficient of the API, S is the area available for diffusion, C1 is the 
concentration of drug in the dosage form, and C2 is the concentration of drug in the 
dissolution medium. 
h
)tCDS(CQ 21−=                            (Eq. 6.1)  
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The changes in the film’s porosity and tortuosity during aging was later related to 
D by Iyer and associates [7] through equation 6.2, where Dw is the diffusion coefficient of 
the drug in water and e and τ are the porosity and tortuosity of the film, respectively. 
 
τ
)(eDD w=                  (Eq. 6.2) 
Thus during aging, the variation in diffusivity is a direct consequence of 
diminishing porosity and increasing tortuosity of the polymeric film coating. 
Several strategies have been proposed to resolve the problem of physical aging in 
acrylic polymers that have been employed for the film coating of sustained release 
dosage forms.  These include the addition of high levels of plasticizer [1] or talc [8], the 
inclusion of immiscible, water soluble non-ionic excipients [5] or proteins [9], and the 
addition of silicon dioxide to the polymeric coating formulation [10].  Another avenue of 
research that has been described in previous reports is the blending of high Tg polymers 
which are miscible with the functional coating.  Wu and coworkers [11] found that a 
blend of Eudragit® RS 30 D and Eudragit® L 100-55 at a 3:1 ratio provided a stable 
release rate of theophylline from coated pellets when the dosage forms were stored at 
40°C.  The two materials formed a miscible composite that had a Tg of 44°C and the 
mechanism of stabilization was due to a decrease in the molecular mobility of polymer 
chains in the film.  In a similar study [12], Zheng and coworkers investigated the 
influence of Eudragit® L 30 D-55 on the stability of Eudragit® NE 30 D films.  They 
reported that films of a 5:1 blend of Eudragit® NE 30 D:L 30 D-55 equilibrated over a 
shorter period of time and that the release rate of phenylpropanolamine hydrochloride 
from pellets coated with the polymeric blend  showed improved stability when compared 
to pellets coated with a formulation containing only Eudragit® NE 30 D. 
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The objective of the present study was to investigate the effect of blending 
Eudragit® NE 30 D with Eudragit® RS 30 D on the drug release rate and physical 
stability of coated theophylline pellets.  The thermal properties of the components in the 
resulting mixture were examined, as were the physico-mechanical parameters 
(elongation) and water vapor permeability of sprayed films.  It was hypothesized that the 
addition of Eudragit® RS 30 D would stabilize the drug release rate by raising the Tg of 
Eudragit® NE 30 D to the point that film aging would be impeded without compromising 
the film formation during processing. 
6.2 MATERIALS AND METHODS 
6.2.1 Materials 
Eudragit® NE 30 D and Eudragit® RS 30 D dispersions were donated by Degussa, 
Röhm America (Piscataway, NJ, USA).  Anhydrous theophylline and lactose 
monohydrate were both purchased from Spectrum Chemical (Gardena, CA, USA). 
Polyvinylpyrrolidone (Kollidon® K-30) was donated by the BASF Corp. (Mount Olive, 
NJ, USA).  Microcrystalline cellulose (Avicel® PH-101) was donated by the FMC Corp. 
(Newark, DE, USA).  Imperial® 500 USP was generously donated by Luzenac America 
(Englewood, CO). 
6.2.2 Methods 
6.2.2.1 Preparation of Core Pellets 
Anhydrous theophylline (25%), lactose monohydrate (45%) and microcrystalline 
cellulose (25%) were passed through a 30-mesh sieve and then mixed 5 minutes. A 
12.5% w/v aqueous solution of polyvinylpyrrolidone (equivalent to 5% in the final 
formulation) was used as a binder in the wet-massing process. The wet mass was 
extruded using an LCI Benchtop Granulator (Tokyo, JP) at a rotation blade speed of 50 
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rpm. The extrudates were spheronized at 1000 rpm for 2 minutes using a Caleva Model 
120 Spheronizer (Dorset, UK). The pellets were sieved after drying for 24 hours at 40°C, 
and the 16-20 mesh fraction was used for the coating trials. 
6.2.2.2 Preparation of Coating Dispersions 
An equal amount of Eudragit® NE 30 D and Eudragit® RS 30 D dispersions 
(45.83 g of each) were added to a beaker, placed on a magnetic stir plate, and mixed with 
slow agitation for a period of one hour.  13.75 g of Imperial® 500 talc (equal to 50% of 
the dry polymer weight) was added in a separate volume of water (170.0 g) and dispersed 
via high shear mixing with a POLYTRON®. The talc dispersion was added to the acrylic 
blend.  The resulting dispersion had a total solids content of 15% and was allowed to mix 
for a further 10 minutes prior to application to the theophylline pellets.  The final 
dispersion had a total solids content of 15%. 
Eudragit® NE 30 D coating dispersions were prepared by first adding 68.75 g of 
the polymeric latex to a beaker.  A POLYTRON® high shear mixer was used to disperse 
10.31 g of Imperial® 500 talc (equal to 50% of the dry polymer weight) in 127.19 g of 
water.  The talc dispersion was added to the acrylic latex with gentle stirring by a 
magnetic bar and stir plate and allowed to mix for 10 minutes prior to coating.  The final 
dispersion had a total solids content of 15%. 
6.2.2.3 Coating of Theophylline Cores 
A 250-g batch of theophylline pellets was placed in a Strea-1 fluidized-bed coater 
(Aeromatic-Fielder, Bubendorf, SW) and preheated for 10 minutes at 30°C before the 
coating process.  The dispersion was delivered with a Watson-Marlow 520s peristaltic 
pump through marprene tubing.  A 1.2 mm nozzle was used with an atomizing air 
pressure of 25 psi. The inlet temperature was maintained at 29-30°C and the outlet 
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temperature was 25-27°C.  The dispersion was applied at a rate of 1 g/min, to avoid pellet 
agglomeration, until a theoretical weight gain of 2.5% had been reached.  At this time, 
the application rate was increased to 3 g/min.  To prevent the sedimentation of dispersed 
solids, the polymeric dispersion was stirred continuously throughout the coating process.  
After coating, the pellets were dusted with 1.25 g of Imperial® 500 talc (0.5% based on 
the uncoated cores) and cured in a 60°C oven for 18 hours. 
6.2.2.4 Stability Testing and In Vitro Drug Release 
After curing, the coated pellets were placed in aluminum induction-sealed high 
density polyethylene (HDPE) containers with 1.0 g MINIPAX molecular sieve (Impak 
Corporation, Los Angeles, CA) inside the container and stored at both 25°C/60% RH and 
40°C/75% RH for a period of up to 3 months.  Dissolution testing was performed 
according to the United States Pharmacopoeia (USP) 29 Apparatus II (Vankel VK 7000, 
Cary, NC, USA) over a 18-hour period in 900 ml of pH 7.4 (50 mM) phosphate buffer. 
The paddle speed was 50 rpm and the temperature of the media was maintained at 
37±0.2°C. 
Dissolution testing was performed in triplicate with 150 mg of coated pellets 
(containing 30 ± 3 mg API) added to each dissolution vessel.  A volume of 5 ml was 
removed by a Vankel 8000 Autosampler (Cary, NC, USA) at each sampling time point. 
Infinity samples were obtained by mixing with a high-shear homogenizer 
(POLYTRON®, Brinkmann Instruments, Westbury, NY, USA) for 1.5 minutes 
The theophylline content of each sample was analyzed using ultraviolet (UV) 
spectroscopy.  A volume of 150 µL was taken from each sample and placed in a 
corresponding well of a Falcon 96-well UV transparent plate (VWR International, West 
Chester, PA, USA).  An equal volume of pH 7.4 dissolution media was added to each 
well to ensure that the concentrations were in the linear range of the analytical method.  
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The tray was then loaded into a µQuant 96-Well Plate Reader (Bio-Tek Instruments, Inc., 
Winooski, VT, USA) and analyzed for theophylline at a wavelength of 273 nm.  The 
amount of theophylline released was calculated by taking the analyte concentration, 
comparing this to the concentration of the infinity time point, and multiplying by 100 to 
obtain a percentage of theophylline released at each time point. 
6.2.2.5 Free Film Preparation 
Free films were sprayed using a 1:1 ratio of Eudragit® NE 30 D and Eudragit® RS 
30 D, which was then diluted with an equal amount of water to achieve a total solids 
content of 15%.  This dispersion was then allowed to mix with gentle agitation via a 
magnetic stir plate and stir bar for a period of one hour prior to film spraying.  For films 
containing only Eudragit® NE 30 D, the polymer dispersion was diluted with an equal 
amount of water to achieve a solids content of 15%. 
The dispersion was sprayed onto a cylinder covered with Bytac® PTFE film 
rotating at 50 rpm via a Watson-Marlow 520s pump, marprene tubing, and a two fluid 
spray nozzle (Mini Hi-Coater, Vector Corporation, Marion, IA, USA).  The atomizing air 
pressure was set at 0.3 kg/m2 and the pump rate was 0.6 rpm (~1 g/min).  The spray 
apparatus provided an oscillatory motion over a 15 cm linear path at 28 rpm.  The 
distance from the nozzle to the rotating cylinder was 12 cm.  The temperature was 
controlled using two infrared heat lamps.  The temperature was set such that the surface 
of the film was maintained at a temperature of 25-30°C as measured by an infrared 
thermometer.  An amount of 100 g of the coating dispersion was used to create each 
composite film.  After the spraying process was completed, the films were cured at a 
temperature of 60°C for a period of 18 hours.  The films were then removed from the 
oven and cut into specimens for either water vapor permeability trials (circular) or 
physical-mechanical testing trials (rectangular).  These films were then placed in 
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desiccators and stored at 25°C or 40°C for stability studies.  Prior to investigating the 
physico-mechanical properties or water vapor permeability, the films were removed from 
the storage chambers and allowed to equilibrate at 25°C/50% RH for a period of 72 
hours. 
6.2.2.6 Water Vapor Permeability Testing 
The water vapor permeability of the sprayed films was determined according to 
guidelines set forth in ASTM E 96/E 96 - 05 using the desiccant method [13].  The 
thickness of each film was determined using a Mitutoyo Model ID-C1012EBS digital 
micrometer by measuring four points along the circumference and one point at the center 
of a circular sample of film and averaging the values.  The film specimen was secured to 
the open mouth of an aluminum permeability cup (4 cm inner diameter and 3 cm depth) 
containing 20 g of Drierite® desiccant.  The permeability cups (n=3) were accurately 
weighed, placed in a humidity chamber at 23°C/80% RH, and periodically reweighed 
over 96 hours to determine the weight gain.  The water vapor transmission rate (WVT) 
and permeability (P) were calculated using the following equations [13]: 
 




WVTP ×−×= 21                 (Eq. 6.4) 
where G is the weight change, t is the time during which G occurred, A is the test 
area (cup mouth area), S is the saturation vapor pressure at test temperature, R1 and R2 are 
the relative humidity in the test chamber and inside the cup (0% RH for the desiccant 
method), respectively, and d is the thickness of the film. 
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6.2.2.7 Physico-Mechanical Testing 
Stress-strain experiments with the sprayed films were performed using an Instron 
Model 4201 with a 1000 N load cell.  Prior to testing, films were cut into 70 mm x 10 
mm strips (n=5).  The thickness was measured using a Mitutoyo Model ID-C1012EBS 
digital micrometer (Mitutoyo Corp., JP) and the average of five different measurements 
along the length of the film was determined. Stress-strain measurements were conducted 
on the cut films in accordance with ASTM guideline D 882-02 [14] using a gap distance 
of 50mm, load range of 1N and crosshead speed of 25 mm/min.   The elongation of the 
films was calculated using Bluehill v.2.5 software. 
6.2.2.8 Determination of Thermal Properties 
The thermal properties of sprayed films were determined using modulated 
differential scanning calorimetry (MDSC) with a DSC 2920 (TA Instruments, New 
Castle, DE, USA).  Film samples of 5-10 mg were accurately weighed into aluminum 
pans and then sealed.  The samples were analyzed over a range of -20-100°C with a 
nitrogen flow rate of 40 ml/min, a heating rate of 12°C/min, and a modulation rate of 
0.5°C with a period of 40 seconds.   The glass transition temperature (Tg) was 
determined as the midpoint of the transition using Modulated DSC Analysis V 1.1A 
software. 
6.2.2.9 Statistical Analysis 
Statistical analysis of in vitro dissolution data was conducted using the f2 
similarity factor treatment described by Shah and associates [15].  Statistical evaluation 
of the physico-mechanical properties and water vapor permeability of sprayed films was 
conducted with Minitab Release 14 software using the one-way analysis of variance 
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(ANOVA) with α=0.05 for a 95% confidence level and Tukey’s HSD post hoc test was 
used to compare the means of each population. 
6.3  RESULTS AND DISCUSSION 
The lowering of the glass transition temperature (Tg) of a material from 
plasticization is due to the weakening of inter-polymeric bonds, resulting in an increase in 
the polymer chain flexibility.  Acrylic polymers have been traditionally formulated with 
citrate esters (triethyl citrate, acetyl triethyl citrate, tributyl citrate, acetyl tributyl citrate), 
dibutyl sebacate, and triacetin to lower both the minimum film formation temperature and 
the Tg of the polymer.  However, it has been reported that plasticizer loss during storage 
from polymeric systems used in sustained release coating applications influenced the 
physico-mechanical stability of films [16, 17].  Thus, the formulation of a polymeric 
blend for sustained release applications that did not employ volatile plasticizers, yet still 
formed coherent films at low processing temperatures, was of interest. 
The plasticization of a high Tg material can also be achieved by blending it with a 
miscible polymer that possesses a lower Tg [11, 12].  It has been reported that two 
materials have the potential for miscibility if the Hansen solubility parameters have a 
difference which is ≤7 MPa1/2 [18].  The Hansen solubility parameters of both Eudragit® 
NE 30 D and Eudragit® RS 30 D have been calculated at 17.1 MPa1/2 [19], which 
indicated that the two polymers have the potential for miscibility.  Equation 6.5, 
developed by Couchman [20],  has been used [12] to predict the Tg of miscible polymer 
blends, where Tg12 is the glass transition temperature of the composite, Tg1 and w1 are the 
Tg and the weight fraction of the lower Tg polymer, respectively, and Tg2 and w2 are the 
Tg and weight fraction of the higher Tg polymer, respectively.   
 
)()( 221112 wTgwTgTg ×+×=                (Eq. 6.5) 
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Modulated differential scanning calorimetry (MDSC) studies on films prepared 
from Eudragit® NE 30 D and Eudragit® RS 30 D separately showed the Tg to be 12.93°C 
and 67.03°C, respectively.  These values corresponded well with those previously 
reported in the literature [19].  MDSC revealed that 1:1 and 2:1 blends of Eudragit® NE 
30D: Eudragit® RS 30 D were completely miscible at these ratios and showed single 
transitions of 38.09°C and 23.14°C, respectively.  These values were close to the 
predicted values of 39.5°C for the 1:1 blend and 30°C for the 2:1 blend.  Krajacic and 
Tucker [21] have shown that tablets comprising Eudragit® NE 30 D as a polymeric 
matrix-forming material would continue to cure in a dissolution medium heated to 37°C 
if the matrix was incompletely formed.  To negate the effect of dissolution media 
temperature on drug release, formulations composed of a 1:1 ratio of Eudragit® NE 30 
D:RS 30 D with a Tg of 38.09°C were selected for further studies. 
One method used in previous studies to investigate the physical aging of polymers 
is by following the water vapor permeability of thin films [5, 9, 10, 17, 22, 23].  The 
water vapor permeability of sprayed Eudragit® NE 30 D films is shown in Figure 6.1.  
These films were characterized by very low permeability values and exhibited 
statistically significant differences between the initial samples and those stored for one 
month at both 25°C (ANOVA, p=0.004) and 40°C (ANOVA, p=0.001).  Tukey’s HSD 
post hoc analysis (Table 6.1 and Table 6.2) indicated that the permeability at all time 
points were significantly smaller than the permeability of the films initially tested.  
Physical aging of these systems was evident due to a densification and continuing 
coalescence of the low Tg polymer.  The permeability of Eudragit® NE 30 D films could 
be enhanced by blending the polymer with an equal amount of Eudragit® RS 30 D as 
shown in Figure 6.2.  At the initial time point, the water vapor permeability of the 
blended acrylic polymer film was five times greater than value for films comprising 
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Eudragit® NE 30 D alone.  This was attributed to higher permeability of Eudragit® RS 30 
D polymer.  Stability studies showed no statistically significant difference in water vapor 
permeability between films stored at 25°C (ANOVA, p=0.192) or 40°C (ANOVA, 
p=0.361) at all time points and indicated no change in the permeability of the films when 
stored at these conditions. 
The elongation of the polymeric films has been determined to monitor the 
physical aging phenomenon [3, 5, 9, 10, 17].  Changes in these parameters are 
characterized by a relaxation of the polymer toward a state of equilibrium and can be 
influenced by factors such as the amount of plasticizer in the formulation, the length of 
curing time, as well as temperature and humidity storage conditions.  The effect of time 
and temperature on the elongation of sprayed films consisting of a 1:1 blend of Eudragit® 
NE 30 D:RS 30 D are seen in Figure 6.3 and Figure 6.4.  For films stored at 25°C for a 
period of up to one month (Figure 6.3), there was no statistically significant decrease 
(ANOVA, p=0.690) indicating that the films were physically stable at this temperature.  
However, films stored at 40°C (Figure 6.4) did exhibit a significant decrease (ANOVA, 
p=0.001) in elongation over the 1 month testing period.  The results for the post hoc 
Tukey’s HSD analysis are shown in Table 6.3 and indicate that the means of elongation 
at all time points showed a statistically significant decrease in elongation compared to 
that of films initially tested.  While there was no significant change between the means of 
the one and two week time points, both were found to be significantly different from the 
four week time point which indicated that further coalescence and entanglement of the 
polymer chains occurred for films stored at the higher temperature.  This observation 
contradicted the water vapor permeability studies (Figure 6.2), which showed no change 
in that parameter over the same time period under the same storage conditions and was 
 122
attributed to the increased permeability of the polymeric film by the presence of the more 
permeable Eudragit® RS 30 D polymer. 
The release properties of theophylline from Eudragit® NE 30 D coated pellets are 
shown in Figure 6.5.  Coating of the pellets to a 7.5% weight gain with the poorly 
permeable polymer resulted in less than 20% of the drug being released after 18 hours in 
pH 7.4 (50 mM phosphate) buffer.  When a 1:1 blend of Eudragit® NE 30 D: RS 30 D 
was applied to the pellets at a 10% weight gain, the drug release rate increased and more 
than 60% theophylline was released after 18 hours and resulted in a zero-order drug 
dissolution profile after an initial lag time of 1-2 hours.  The increase in drug release 
could be explained by the difference in permeability of films formed by the polymers.  
The chemical makeup of Eudragit® RS 30 D includes quaternary ammonium functional 
groups that undergo hydration and thus promote swelling and permeability of films 
comprising this material.  Eudragit® NE 30 D lacks these functional groups and the drug 
release rate is controlled by the thickness of the film coating.  These findings 
corresponded well to the difference in permeability of free films studied during the water 
vapor permeability trials (Figure 6.1 and Figure 6.2). 
The stability upon storage of theophylline pellets coated with the blend of acrylic 
polymers to a 10% weight gain is shown in Figure 6.6 and Figure 6.7.  After coating and 
curing for 18 hours at 60°C, the pellets were placed in aluminum induction sealed HDPE 
containers with desiccant at storage conditions of 25°C/60% RH and 40°C/75% RH for a 
period of up to 3 months.  Coated pellets stored at the lower temperature (Figure 6.6) 
were stable during the 3 month period, with an f2 similarity factor of 78 between the 
initial dosage forms and those stored for 3 months.  In contrast, those pellets stored at the 
higher temperature (Figure 6.7) exhibited a decrease in drug release rate during this time 
period and the f2 similarity factor for the drug release rate between the initial dosage 
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forms and those stored for three months was 53.  Though no change in water vapor 
permeability was seen for sprayed films stored at 40°C, the difference between this 
parameter and dissolution performance was confirmed by the results of the physico-
mechanical properties of the sprayed films, in which there was a significant decrease in 
elongation for these samples (Figure 6.4).  The films were stored at a temperature which 
was above the Tg of the polymeric composite and dissolution was performed at a 
temperature below the Tg.  At this point, the molecular mobility of the polymer chains is 
high and continuing coalescence and densification of the polymer occurred during 
storage.  During dissolution, hydrodynamic effects are exerted on the coated pellets, 
including diffusion of water to the core.  The increase in core volume due to osmotic 
effects causes the film to expand.  Increased coalescence of the polymer during storage at 
temperatures above the Tg significantly affected the ability of the film to expand during 
dissolution and the reduction in drug release rate was a direct result of the instability in 
the elasticity parameter of the film.   
6.4 CONCLUSIONS 
The combination of the miscible polymers Eudragit® NE and Eudragit® RS 30 D   
allowed film formation without the requirement of a plasticizer in the formulation.  Films 
containing a 1:1 blend of Eudragit® NE 30 D:RS 30 D possessed a glass transition 
temperature that was higher than those films consisting of a 2:1 blend and corresponded 
well to predicted values.  Sprayed films composed of Eudragit® NE 30 D:RS 30 D (1:1) 
and theophylline pellets coated with the same formulation possessed higher water vapor 
permeability values and drug release rates, respectively, when compared to Eudragit® NE 
30 D sprayed films and film-coated dosage forms.  This was attributed to the quaternary 
ammonium groups present in Eudragit® RS 30 D which increased the swellability and 
permeability of the film.  Theophylline pellets coated with a blend of Eudragit® NE 30 
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D:RS 30 D (1:1) demonstrated a decrease in drug release rate when stored at 40°C/75% 
RH in aluminum induction sealed HDPE containers.  The release properties of coated 
pellets could be correlated to instabilities in the physico-mechanical properties of sprayed 
films, which showed a decrease in percent elongation during a time period of 4 weeks 
when stored at 40°C. This reduced flexibility of the film coating during dissolution was 
due to increased coalescence and interdiffusion of the polymer chains when stored at 
temperatures above the Tg of the polymeric blend.  However, when the same pellets were 
stored at 25°C/60% RH (below the glass transition temperature of the blend), the 
mechanical properties of the films were conserved and no change in drug release rate 
were observed over a 3 month period.  The stability of Eudragit® NE 30 D films could be 
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6.6 TABLES 
 Initial 1 Week 2 week 
1 Week X   
2 Weeks X O  
4 Weeks X O O 
Table 6.1 Pair-wise comparisons performed by Tukey’s HSD post hoc analysis with a 
95% simultaneous confidence interval of the water vapor permeability of 
Eudragit® NE 30 D sprayed films stored at 25°C for a period of up to 4 




 Initial 1 Week 2 Week 
1 Week X   
2 Weeks X O  
4 Weeks X O O 
Table 6.2 Pair-wise comparisons performed by Tukey’s HSD post hoc analysis with a 
95% simultaneous confidence interval of the water vapor permeability of 
Eudragit® NE 30 D sprayed films stored at 40°C for a period of up to 4 
weeks (X, significant difference; O, no significant difference). 
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 Initial 1 Week 2 Weeks 
1 Week X   
2 Weeks X O  
4 Weeks X X X 
Table 6.3 Pair-wise comparisons performed by Tukey’s HSD post hoc analysis with a 
95% simultaneous confidence interval of the percent elongation of 
Eudragit® NE 30 D:Eudragit® RS 30 D (1:1) sprayed films stored at 40°C 
for a period of up to 4 weeks (X, significant difference; O, no significant 
difference). 
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Figure 6.1 The effect of temperature and time on the water vapor permeability of 


























Figure 6.2 The effect of temperature and time on the water vapor permeability of 
Eudragit® NE 30 D:Eudragit® RS 30 D (1:1) sprayed films ( , 25°C; , 






















Figure 6.3 The influence of temperature and time on the percent elongation properties of 























Figure 6.4 The influence temperature and time on the percent elongation properties of 
























Figure 6.5 The influence of the addition of Eudragit® RS 30 D on the release of 
theophylline from coated pellets ( , Eudragit® NE 30 D:Eudragit® RS 30 D 
(1:1), 50% Imperial® 500 talc, 10% W.G.; , Eudragit® NE 30 D, 50% 
Imperial® 500 talc, 7.5% W.G.) (USP 29 Apparatus II, 900 ml pH 7.4 























Figure 6.6 The influence of storage time on the release of theophylline (30 mg) from 
pellets coated with Eudragit® NE 30 D:Eudragit® RS 30 D (1:1) and 50% 
Imperial® 500 talc coated to a 10% weight gain and stored in sealed HDPE 
containers with desiccant at 25°C/60% RH ( , initial; , 2 week; , 1 
month; , 3 month)(USP 29 Apparatus II, 900 ml pH 7.4 buffered 






















Figure 6.7 The influence of storage time on the release of theophylline (30 mg) from 
pellets coated with Eudragit® NE 30 D:Eudragit® RS 30 D (1:1) and 50% 
Imperial® 500 talc coated to a 10% weight gain and stored in sealed HDPE 
containers with desiccant at 40°C/75% RH ( , initial; , 2 week; , 1 
month; , 3 month)(USP 29 Apparatus II, 900 ml pH 7.4 buffered 
phosphate solution, 50 rpm, 37°C, n=3). 
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Chapter 7: Conclusions 
7.1 THE USE OF PROTEINS TO MINIMIZE THE PHYSICAL AGING OF EUDRAGIT® 
SUSTAINED RELEASE FILMS 
The influence of the addition of bovine serum albumin and Type B gelatin on the 
physical aging and physico-mechanical properties of 95:5 blends of Eudragit® RS30 
D:RL 30 D was investigated.  Coating formulations of the acrylic dispersions plasticized 
with 15% TEC and containing 10% Type B gelatin were shown to enhance the 
theophylline release rate from film-coated pellets, which was attributed to the formation 
of gel domains in which the drug was able diffuse through easily.  Adjustment of the 
acrylic dispersion pH to more acidic values did not impact drug release.  The zeta 
potential of the blend was maintained due to the isoelectric point of the gelatin being 
above that of the acrylic dispersion.  While the physico-mechanical parameters of 
sprayed films indicated aging in these systems, the water vapor permeability values 
remained constant during a one month period when stored in open containers under 
conditions of 40°C/75% RH.  It was shown that the addition of Type B gelatin to 
Eudragit® RS/RL 30 D dispersions stabilized the drug release rate from coated 
theophylline pellets stored in both open and closed containers at 40°C/75% RH over a 
period of 3 months.  The mechanism of stabilization in these films was attributed to the 
maintenance in permeability of the films.  On the other hand, the inclusion of 10% bovine 
serum albumin to the coating dispersions exhibited an increase in particle size and a 
decrease in colloidal electrostatic charge due to electrostatic interactions between the 
positively charged quaternary ammonium groups of the polymer and the protein which 
was negatively charged at the native dispersion pH.  Significant decreases in the water 
vapor permeability and changes in the physico-mechanical properties of sprayed films 
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indicated significant aging in these systems which corresponded to the decrease in drug 
release rate observed over a period of six months at 40°C/75% RH in open containers.  
Dissolution media was found to influence the surface charge of albumin in the acrylic 
films and the protein was released in 0.1 N HCl but remained in the films at pH 7.4, 
indicating that the drug release rate would not be affected by the formation of pores 
during dissolution.  Physically stable films were formed by adjusting the pH of the 
acrylic dispersion to 2.5, below the isoelectric point of albumin, and the stabilization in 
drug release rate from theophylline pellets coated with this formulation and stored at 
40°C/75% RH and 25°C/60% RH was attributed to like-like repulsive forces between the 
two positively charged components.   
7.2 INFLUENCE OF FUMED SILICON DIOXIDE ON THE STABILIZATION OF 
EUDRAGIT® RS/RL 30 D FILM-COATED THEOPHYLLINE PELLETS 
The effects of silicon dioxide on the drug release rate and physical stability of 
Eudragit® RS/RL 30 D films were the aims of this study.  Silicon dioxide with particle 
sizes in the colloidal range (Cab-O-Sil® M-5P and Aerosil® 200 VV) exhibited enhanced 
incorporation of the excipient into the polymeric film.  Pellets coated with these 
formulations displayed drug release rates and water vapor permeability values that were 
significantly lower than those pellets coated with the larger particle size Aeroperl® 300, 
which was found to be present in the film in large agglomerates.  Theophylline pellets 
coated to a 20% weight gain of Eudragit® RS 30 D, 15% TEC, and 30% Aeroperl® 300 
exhibited zero-order release kinetics and were stable during a storage period of 2 months 
at 25°C/60% RH in sealed HDPE containers.  The mechanism of stability was due to the 
water vapor permeability of sprayed films, which showed no change during storage at 
25°C.  Changes in the theophylline release rate of pellets coated with a 90:10 blend of 
Eudragit® RS 30 D:RL 30 D plasticized with 15% TEC and containing either Cab-O-Sil® 
 140
M-5P or Aerosil® 200 VV coincided with small changes in the water vapor permeability 
of cast films which showed slight statistical decreases and increases, respectively. 
7.3 THE INFLUENCE OF ETHYLCELLULOSE POLYMERS ON THE PHYSICAL 
STABILITY OF THEOPHYLLINE PELLETS COATED WITH EUDRAGIT® NE 30 D 
The particle size of Ethocel® S4 was found to influence the release of 
theophylline pellets coated with Eudragit® NE 30 D in that those formulations containing 
larger particle size ethylcellulose powder exhibited a decrease in drug release compared 
to smaller particle size ethylcellulose.  The Hansen solubility parameters of the acrylic 
and cellulosic polymers indicated possible miscibility between the two materials; 
however, thermal data showed that the miscible phase was only a small fraction of the 
total composite and the films were largely composed of ethylcellulose powdered 
dispersed in Eudragit® NE 30 D.  The addition of Ethocel® 7 FP to the coating dispersion 
increased the permeability of the films and accelerated the rate at which theophylline was 
released from the coated pellets.  The formation of pores and channels in these films 
during dissolution was attributed to the loss of ethylcellulose from the film, which 
occurred during the swelling of the polymer during dissolution.  Theophylline pellets 
coated with a 2:1 blend of Eudragit® NE 30 D:Ethocel® 7 FP exhibited a stable drug 
release rate over the course of 3 months at both 25°C/60% RH and 40°C/75% RH when 
stored in aluminum induction sealed HDPE containers.  The stabilization in drug release 
rate was attributed to constant water vapor permeability values and physico-mechanical 
properties of the sprayed films.  The presence of Ethocel® 7 FP in the Eudragit® NE 30 D 
films prevented the densification and further coalescence of the polymer at temperatures 
well above the glass transition temperature of the acrylic polymer. 
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7.4 INFLUENCE OF AN ACRYLIC POLYMER BLEND ON THE PHYSICAL STABILITY OF 
FILM-COATED THEOPHYLLINE PELLETS 
The requirement of a plasticizer to aid in film formation was not necessary when 
Eudragit® RS 30 D and Eudragit® NE 30 D were blended.  The glass transition 
temperature of the blend was affected by the ratio in which the polymers were present 
and were found to be close to predicted values.  Sprayed films consisting of a 1:1 blend 
of Eudragit® NE 30 D:Eudragit® RS 30 D possessed water vapor permeability values that 
were five times those values of Eudragit® NE 30 D alone and was due to the presence of 
the quaternary ammonium groups in the chemical structure of Eudragit® RS 30 D.  
Theophylline pellets stored at 40°C/75% RH in aluminum induction sealed HDPE 
containers exhibited a decrease in drug release rate over a 3 month period of time due to a 
further densification of the acrylic film when stored above the glass transition 
temperature of the polymeric blend.  On the other hand, those pellets stored in aluminum 
induction sealed HDPE containers with desiccant at 25°C/60% RH exhibited excellent 
stability due to storage at temperatures below the Tg of the polymer.  The decrease in 
drug release rate was attributed to instabilities in the mechanical properties of the sprayed 
polymeric films, which showed a reduction in elongation for films stored at the higher 
temperature and was due to increased coalescence and interdiffusion of the polymer 
chains at storage conditions above the Tg of the polymer blend. 
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